10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended May 31, 2023

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________________________ to __________________________

Commission file number 000-55517

PUREBASE CORPORATION

(Exact name of registrant as specified in its charter)

Nevada	27-2060863
(State or other Jurisdiction	(I.R.S. Employer
of Incorporation or Organization)	Identification No.)

8631 State Highway 124
Ione, California	95640
(Address of Principal Executive Offices)	(Zip Code)

(209) 274-9143

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbol(s)	Name of each exchange on which registered
None	N/A	N/A

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, par value $0.001

(Title of class)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a small reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” or an “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act: ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of July 14, 2023, there were 230,863,005 shares of the registrant’s common stock outstanding.

PUREBASE CORPORATION AND SUBSIDIARIES

FOR THE QUARTERLY PERIOD ENDED MAY 31, 2023

		Page
PART I. FINANCIAL INFORMATION
ITEM 1.	FINANCIAL STATEMENTS (UNAUDITED)
	CONDENSED CONSOLIDATED BALANCE SHEETS AS OF MAY 31, 2023 AND NOVEMBER 30, 2022	3
	CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE AND SIX MONTHS ENDED MAY 31, 2023 AND MAY 31, 2022	4
	CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIT FOR THE THREE AND SIX MONTHS ENDED MAY 31, 2023 AND MAY 31, 2022	5
	CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED MAY 31, 2023 AND MAY 31, 2022	6
	NOTES TO CONDENSED CONSOLIDTED FINANCIAL STATEMENTS	7
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	26
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	32
ITEM 4.	CONTROLS AND PROCEDURES	32
PART II. OTHER INFORMATION		33
ITEM 1.	LEGAL PROCEEDINGS	33
ITEM 1A.	RISK FACTORS	33
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITES AND USE OF PROCEEDS	33
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	33
ITEM 4.	MINE SAFETY DISCLOSURES	33
ITEM 5.	OTHER INFORMAION	34
ITEM 6.	EXHIBITS	34
SIGNATURES		35

2

PUREBASE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	May 31, 2023			November 30, 2022
	(Unaudited)
ASSETS
Current Assets:
Cash and cash equivalents	$	23,248		$	19,055
Accounts receivable		66,376			-
Prepaid expenses and other assets		1,184			4,731
Total Current Assets		90,808			23,786
Property and equipment, net		620,000			620,000
Right of use asset		59,699			79,599
Total Assets	$	770,507		$	723,385
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities:
Accounts payable and accrued expenses	$	412,557		$	115,478
Settlement liability		-			400,000
Lease liability, current		39,869			38,882
Note payable to officer		13,716			28,716
Convertible notes payable, related party		12,000			36,000
Notes payable, related party		-			25,000
Total Current Liabilities		478,142			644,076
Lease liability, net of current portion		20,696			40,880
Convertible notes payable; related party, net of current portion		1,331,742			610,889
Total Liabilities		1,830,580			1,295,845
Commitments and Contingencies (Note 9)
Stockholders’ Deficit:
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding, at May 31, 2023 and November 30, 2022		-			-
Common stock, $0.001 par value; 520,000,000 shares authorized; 230,763,005 and 230,753,005 shares issued and outstanding, at May 31, 2023 and November 30, 2022, respectively		160,360			160,350
Additional paid in capital		60,273,231			52,910,839
Accumulated deficit		(61,493,664	)		(53,643,649	)
Total Stockholders’ Deficit		(1,060,073	)		(572,460	)
Total Liabilities and Stockholders’ Deficit	$	770,507		$	723,385

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

PUREBASE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	For the Three Months Ended						For the Six Months Ended
	May 31, 2023			May 31, 2022			May 31, 2023			May 31, 2022
Revenue, net	$	66,376		$	228,476		$	118,632		$	228,476
Cost of goods sold		26,606			88,030			49,069			91,282
Operating Income		39,770			140,446			69,563			137,194
Operating Expenses:
Selling, general and administrative		2,321,585			7,622,810			8,208,455			18,823,211
Total Operating Expenses		2,321,585			7,622,810			8,208,455			18,823,211
Loss From Operations		(2,281,815	)		(7,482,364	)		(8,138,892	)		(18,686,017	)
Other Income (Expense):
Other income		275,000			-			310,401			2,007
Interest expense		(12,401	)		(11,013	)		(21,524	)		(31,911	)
Total Other Income (Expense), net		262,599			(11,013	)		288,877			(29,904	)
Net Loss	$	(2,019,216	)	$	(7,493,377	)	$	(7,850,015	)	$	(18,715,921	)
Loss per Common Share - Basic and Diluted	$	(0.01	)	$	(0.03	)	$	(0.03	)	$	(0.08	)
Weighted Average Shares Outstanding - Basic and Diluted		230,473,222			229,316,070			230,609,928			222,424,978

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

PUREBASE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR THE THREE AND SIX MONTHS ENDED MAY 31, 2023 AND 2022

(Unaudited)

											Additional
	Preferred Stock				Common Stock						Paid-in		Accumulated			Stockholders’
	Shares		Amount		Shares			Amount			Capital		Deficit			Deficit
Balance at November 30, 2021		-	$	-		215,380,751		$	144,977		$	18,730,863	$	(21,061,224	)	$	(2,185,384	)
Stock based compensation - shares		-		-		-			-			10,949,738		-			10,949,738
Net loss		-		-		-			-			-		(11,222,544	)		(11,222,544	)
Balance as of February 28, 2022		-	$	-		215,380,751		$	144,977		$	29,680,601	$	(32,283,768	)	$	(2,458,190	)
Stock based compensation - shares		-		-		-			-			7,304,345		-			7,304,345
Convertible debt converted into common stock		-		-		23,741,655			23,742			2,549,429		-			2,573,171
Net loss		-		-		-			-			-		(7,493,377	)		(7,493,377	)
Balance at May 31, 2022		-	$	-		239,122,406		$	168,719		$	39,534,375	$	(39,777,146	)	$	(74,052	)
Balance at November 30, 2022		-	$	-		230,753,005		$	160,350		$	52,910,839	$	(53,643,649	)	$	(572,460	)
Stock based compensation - shares		-		-		-			-			5,485,013		-			5,485,013
Settlement share surrender		-		-		(300,000	)		(300	)		300		-			-
Net loss		-		-		-			-			-		(5,830,799	)		(5,830,799	)
Balance as of February 28, 2023		-	$	-		230,453,005		$	160,050		$	58,396,152	$	(59,474,448	)	$	(918,246	)
Stock based compensation - shares		-		-		-			-			1,841,389		-			1,841,389
Conversion of board of director accrued debt		-		-		310,000			310			35,690		-			36,000
Net loss		-		-		-			-			-		(2,019,216	)		(2,019,216	)
Balance at May 31, 2023		-	$	-		230,763,005		$	160,360		$	60,273,231	$	(61,493,664	)	$	(1,060,073	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

PUREBASE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	For the Six Months Ended
	May 31, 2023			May 31, 2022
Cash Flows From Operating Activities:
Net loss	$	(7,850,015	)	$	(18,715,921	)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation		7,326,402			18,254,083
Amortization of debt discount		-			5,329
Non-cash director compensation		12,000			-
Gain on debt forgiveness		(35,401	)		-
Gain on settlement		(275,000	)		-
Changes in operating assets and liabilities:
Accounts receivable		(66,376	)		(35,696	)
Prepaid expenses and other assets		3,547			3,446
Right of use asset		19,900			-
Accounts payable and accrued expenses		323,333			62,979
Settlement liability		(125,000	)		-
Change in settlement liability		(19,197	)		-
Net Cash Used In Operating Activities		(685,807	)		(425,780	)
Cash Flows From Financing Activities:
Advances from related party		705,000			410,000
Payments on notes payable, related party		(15,000	)		(10,000	)
Net Cash Provided By Financing Activities		690,000			400,000
Net Increase (Decrease) In Cash and Cash Equivalents		4,193			(25,780	)
Cash and Cash Equivalents - Beginning of Period		19,055			132,309
Cash and Cash Equivalents - End of Period	$	23,248		$	106,529
Supplemental Cash Flow Information:
Noncash operating and financing activities:
Forgiveness of accounts payable due to USMC	$	(15,853	)	$	-
Vendors paid for on behalf of the Company by USMC	$	8,320		$	4,282
Expenses paid for on behalf of the Company by USMC	$	7,533		$	-
Due to affiliates exchanged for convertible debt	$	-		$	884,493
Convertible debt converted to common stock	$	-		$	2,464,262
Accrued interest converted to common stock	$	-		$	108,909
Director compensation - accrued as convertible debt converted to common stock	$	36,000		$	-

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

PUREBASE CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1 – ORGANIZATION AND BUSINESS OPERATIONS

Corporate Overview

PureBase Corporation (“PureBase” or the “Company”) was incorporated in the State of Nevada on March 2, 2010. The Company is an industrial mineral and natural resource company that provides solutions to the agriculture and construction materials markets in the United States through its two subsidiaries, PureBase Agricultural, Inc., a Nevada corporation (“PureBase AG”), and U.S. Agricultural Minerals, LLC, a Nevada limited liability company (“PureBase SCM”), respectively.

The Company is headquartered in Ione, California.

Agricultural Sector

The Company develops specialized fertilizers, sun protectants, soil amendments and bio-stimulants for organic and non-organic sustainable agriculture. The Company has developed and will seek to develop additional products derived from mineralized materials of leonardite, kaolin clay, laterite, and other natural minerals. These mineral and soil amendments are used to protect crops, plants and fruits from the sun and winter damage, to provide nutrients to plants, and to improve dormancy and soil ecology to help farmers increase the yields of their harvests. The Company is building a brand family under the parent trade name “PureBase,” consisting of its PureBase Shade Advantage (WP) product, a kaolin-clay based sun protectant for crops and Humic Advantage, a humic acid product derived from leonardite.

Construction Sector

The Company has been developing and testing a kaolin-based product that it believes will help create a lower CO2-emitting concrete through the use of high-quality supplementary cementitious materials (“SCMs”). The Company is developing an SCM that it believes can potentially replace up to 40% of cement, the most polluting part of concrete. As government agencies continue to enact stricter requirements for less-polluting forms of concrete, the Company believes there are significant opportunities for high-quality SCM products in the construction-materials sector.

The Company utilizes the services of US Mine Corporation (“USMC”), a Nevada corporation and a significant shareholder of the Company, for the development and contract mining of industrial mineral and metal projects, exploration drilling, preparation of feasibility studies, mine modeling, on-site construction, production, site reclamation, and product fulfillment. Exploration services include securing necessary permits, environmental compliance, and reclamation plans. In addition, a substantial portion of the minerals used by the Company are obtained from properties owned or controlled by USMC. A. Scott Dockter, the Company’s Principal Executive Officer and a director, and John Bremer, a director, are also officers, directors, and owners of USMC.

NOTE 2 – GOING CONCERN AND LIQUIDITY

The accompanying condensed consolidated financial statements have been prepared on the basis that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. As of May 31, 2023, the Company had a significant accumulated deficit of $61,493,664 and working capital deficit of $387,334. For the six months ended May 31, 2023, the Company had a loss from operations of $8,138,892 and negative cash flows from operations of $685,807. The Company’s operating activities consume the majority of its cash resources. The Company anticipates that it will continue to incur operating losses as it executes its development plans for 2023. In addition, the Company has had and expects to have negative cash flows from operations, at least into the near future. The Company has previously funded, and plans to continue funding, these losses primarily with additional infusions of cash from advances from USMC and the sale of equity and convertible notes. The accompanying condensed consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.

7

The Company’s plan, through the continued promotion of its products to existing and potential customers, is to generate sufficient revenues to cover its anticipated expenses. The Company is currently exploring several options to meet its short-term cash requirements, including future line of credits and issuances of equity securities or equity-linked securities to USMC and other third parties.

Although no assurances can be given as to the Company’s ability to deliver on its revenue plans or that unforeseen expenses may arise, management currently believes that the revenue to be generated from operations together with equity and debt financing, including funding from USMC in connection with the March 23, 2022 securities purchase agreement, March 7, 2023 securities purchase agreement, and July 10, 2023 line of credit agreement will provide the necessary funding for the Company to continue as a going concern for the next twelve months. The March 23, 2022 securities purchase agreement provides for the issuance by the Company of up to an aggregate of $1,000,000 of two-year convertible promissory notes to USMC (See Note 6). The notes bear interest at 5% per annum and any outstanding principal or interest under the notes are convertible into shares of the Company’s common stock, at any time at the option of the holder, at a conversion price of $0.39 per share. Currently, the Company has issued $919,209 of convertible notes under the March 23, 2022 securities purchase agreement and may issue an additional $80,791 of convertible notes. The March 7, 2023 securities purchase agreement provides for the issuance by the Company of up to an aggregate of $1,000,000 of two-year convertible promissory notes to USMC (See Note 6). The notes bear interest at 8% per annum and any outstanding principal or interest under the notes are convertible into shares of the Company’s common stock, at any time at the option of the holder, at a conversion price of $0.10 per share. Currently, the Company has issued $412,533 of convertible notes under the March 7, 2023 securities purchase agreement and may issue an additional $587,467 of convertible notes under such agreement. The July 10, 2023 line of credit agreement provides for the issuance for up to one year of up to an aggregate of $1,000,000 of advances from USMC under an unsecured convertible grid promissory note (See Note 12). The note bears interest at 8% annum and any outstanding principal or accrued interest under the note is convertible into shares of the Company’s common stock at a conversion price of $0.10 per share on the maturity date. As of the date hereof, there have been no advances from USMC under the July 10, 2023 line of credit agreement. There currently are no other arrangements or agreements for financing, and management cannot guarantee any other potential debt or equity financing will be available, or if available, on favorable terms. As such, these matters raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date of this report. If adequate funds are not available on acceptable terms, or at all, the Company will need to curtail operations, or cease its operations completely.

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) including Form 10-Q and Regulation S-X. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments, unless otherwise indicated) which are, in the opinion of management, necessary to fairly state the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been omitted pursuant to such rules and regulations. These financial statements and the information included under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read in conjunction with the audited financial statements and notes thereto for the year ended November 30, 2022 in our Annual Report on Form 10-K filed on February 28, 2023 with the SEC. The results of the six months ended May 31, 2023 (unaudited) are not necessarily indicative of the results to be expected for the full year ending November 30, 2023.

Principles of Consolidation

These condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries PureBase AG and PureBase SCM. Intercompany accounts and transactions have been eliminated upon consolidation.

8

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and equity-based transactions at the date of the financial statements and the revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the condensed consolidated financial statements. Significant estimates include the useful lives of property and equipment, deferred tax asset and valuation allowance, and assumptions used in the Black-Scholes valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.

Revenue

The Company accounts for revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers. The Company derives revenues from the sale of products from its agricultural sector and construction sector. The Company’s contracted transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The Company’s contracts have a single performance obligation which are not separately identifiable from other promises in the contracts and is, therefore, not distinct. The Company’s performance obligation is satisfied upon the transfer of risk of loss to the customer.

Practical Expedients

As part of ASC Topic 606, the Company has adopted several practical expedients including:

● Significant Financing Component – the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to the customer and when the customer pays for that good or service will be one year or less.

● Unsatisfied and Partially Unsatisfied Performance Obligations – for all performance obligations related to contracts with a duration for less than one year, the Company has elected to apply the optional exemption provided in ASC Topic 606 and therefore is not required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially satisfied at the end of the reporting period.

● Shipping and Handling Activities – the Company elected to account for shipping and handling activities as a fulfillment cost rather than as a separate performance obligation.

● Right to Invoice – the Company has a right to consideration from a customer in an amount that corresponds directly with the value provided to the customer of the Company’s performance completed to date. The Company may recognize revenue in the amount to which the entity has a right to invoice.

9

Disaggregated Revenue

Revenue consists of the following by product offering for the six months ended May 31, 2023:

CROP WHITE II		SHADE ADVANTAGE (WP)		SulFe Hume Si ADVANTAGE		Total
$	-	$	67,152	$	51,480	$	118,632

Revenue consists of the following by product offering for the six months ended May 31, 2022:

CROP WHITE II		SHADE ADVANTAGE (WP)		SulFe Hume Si ADVANTAGE		Total
$	192,780	$	35,696	$	-	$	228,476

Cash and Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. There were no cash equivalents as of May 31, 2023 and November 30, 2022.

Accounts Receivable

The Company periodically assesses its accounts and other receivables for collectability on a specific identification basis. If collectability of an account becomes unlikely, an allowance is recorded for that doubtful account. As of May 31, 2023 and November 30, 2022, the Company has determined that no allowance for doubtful accounts was necessary.

Property and Equipment

 Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, generally three to five years. Expenditures that enhance the useful lives of the assets are capitalized and depreciated.

Equipment	3-5 years
Autos and trucks	5 years

Maintenance and repairs are charged to expense as incurred. At the time of retirement or other disposition of property and equipment, the cost and accumulated depreciation will be removed from the accounts and the resulting gain or loss, if any, will be reflected in operations. The Company currently has $620,000 in property and equipment, primarily two ball mills, acquired on May 1, 2020. As of May 31, 2023, the Company has not put the acquired property and equipment to use. As such, the Company has not recorded depreciation related to these assets.

Impairment of Long-Lived Assets

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of these assets is determined by comparing the forecasted undiscounted net cash flows of the operation to which the assets relate to the carrying amount. If the operation is determined to be unable to recover the carrying amount of its assets, then these assets are written down first, followed by other long-lived assets of the operation to fair value. Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets. No impairment losses were recorded during the three and six months ended May 31, 2023 and May 31, 2022.

Shipping and Handling

The Company incurs shipping and handling costs which are charged back to the customer. The Company did not incur shipping and handling costs during the three months ended May 31, 2023 and 2022, respectively. The Company incurred shipping and handling costs of $2,000 and no shipping and handling costs during the six months ended May 31, 2023 and 2022, respectively.

10

Advertising and Marketing Costs

The Company expenses advertising and marketing costs as incurred and such costs are recorded in selling, general and administrative expenses in the accompanying condensed consolidated statements of operations. Advertising and marketing expenses were $2,643 for the three and six months ended May 31, 2023. There were no advertising and marketing expenses for the three and six months ended May 31, 2022.

Fair Value Measurements

As defined in ASC 820, Fair Value Measurements and Disclosures, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.

Level 1:	Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
Level 2:	Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.
Level 3:	Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

Fair Value of Financial Instruments

The carrying value of cash, accounts receivable, accounts payable, and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amount of notes approximates the estimated fair value for these financial instruments as management believes that such notes constitute substantially all of the Company’s debt and interest payable on the notes based on the Company’s incremental borrowing rate.

Loss Per Common Share

Net loss per share of common stock is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the three and six month periods ended May 31, 2023 and 2022. All outstanding options are considered potential common stock. The dilutive effect, if any, of stock options are calculated using the treasury stock method. All outstanding convertible notes are considered common stock at the beginning of the period or at the time of issuance, if later, pursuant to the if-converted method. Since the effect of common stock equivalents is anti-dilutive with respect to losses, outstanding options have been excluded from the Company’s computation of net loss per share of common stock for the three and six months ended May 31, 2023 and May 31, 2022.

11

The following table summarizes the stocks that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive due to the Company’s net loss position even though the exercise price could be less than the average market price of the common stock:

	Three Months Ended,
	May 31, 2023		May 31, 2022
Convertible Notes		6,656,110		-
Stock Options		128,688,187		1,595,000
Total		135,344,297		1,595,000

	Six Months Ended,
	May 31, 2023		May 31, 2022
Convertible Notes		6,656,110		-
Stock Options		128,688,187		59,595,000
Total		135,344,297		59,595,000

Stock-Based Compensation

The Company applies the provisions of ASC 718, Compensation—Stock Compensation (“ASC 718”), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees, including employee stock options, in the accompanying condensed consolidated statements of operations.

For stock options issued to employees and members of the Company’s Board of Directors (the “Board”) for their services, the Company estimates the grant date fair value of each option using the Black-Scholes option pricing model. The use of the Black-Scholes option pricing model requires management to make assumptions with respect to the expected term of the option, the expected volatility of the common stock consistent with the expected life of the option, risk-free interest rates and expected dividend yields of the common stock. For awards subject to service-based vesting conditions, including those with a graded vesting schedule, the Company recognizes stock-based compensation expense equal to the grant date fair value of stock options on a straight-line basis over the requisite service period, which is generally the vesting term. Forfeitures are recorded as they are incurred as opposed to being estimated at the time of grant and revised.

Pursuant to ASU 2018-07 Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, the Company accounts for stock options issued to non-employees for their services in accordance with ASC 718. The Company uses valuation methods and assumptions to value the stock options that are in line with the process for valuing employee stock options as noted above.

Leases

With the adoption of ASC 842, Leases, operating lease agreements are required to be recognized on the balance sheet as Right-of-Use (“ROU”) assets and corresponding lease liabilities. ROU assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The lease terms may include options to extend or terminate the lease if it is reasonably certain that the Company will exercise that option.

12

The Company leases its corporate offices. All of the leases are classified as operating leases. The Company is a party to a two-year lease with USMC for 1,000 square feet of office space located in Ione, California (the “Ione Lease”) with respect to its corporate operations (See Note 7). Effective November 1, 2022, the Ione Lease was amended to extend the lease through October 2024 and to add an additional 700 square feet of office space for a total monthly rental price of $3,500 per month, with automatic one-month renewals. The remaining weighted average term is 1.4 years. The Company discounted lease payments using its estimated incremental borrowing rate at December 1, 2020. The weighted average incremental borrowing rate applied was 5%.

In accordance with ASC 842, the Company recognized a ROU asset and corresponding lease liability on the condensed consolidated balance sheet for long-term office leases. See Note 7 – Leases for further discussion, including the impact on the accompanying unaudited condensed consolidated financial statements and related disclosures.

Income Taxes

Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the condensed consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.

The Company utilizes ASC 740, Income Taxes, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the condensed consolidated financial statements or tax returns. The Company accounts for income taxes using the asset and liability method to compute the differences between the tax basis of assets and liabilities and the related financial amounts, using currently enacted tax rates. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

For uncertain tax positions that meet a “more likely than not” threshold, the Company recognizes the benefit of uncertain tax positions in the condensed consolidated financial statements. The Company’s practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in the condensed consolidated statements of operations.

Exploration Stage

In accordance with U.S. GAAP, expenditures relating to the acquisition of mineral rights are initially capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time as the Company exits the exploration stage by establishing proven or probable reserves. Expenditures relating to exploration activities such as drill programs to establish mineralized materials are expensed as incurred. Expenditures relating to pre-extraction activities are expensed as incurred until such time proven or probable reserves are established for that project, after which expenditures relating to mine development activities for that particular project are capitalized as incurred. As of May 31, 2023, the Company was not engaged in any mine exploration.

Mineral Rights

Acquisition costs of mineral rights are capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time as the Company exits the exploration stage by establishing proven or probable reserves, as defined by the SEC under Industry Guide 7, through the completion of a “final” or “bankable” feasibility study. Expenditures relating to exploration activities are expensed as incurred and expenditures relating to pre-extraction activities are expensed as incurred until such time proven or probable reserves are established for that project, after which subsequent expenditures relating to development activities for that particular project are capitalized as incurred.

Where proven and probable reserves have been established, the project’s capitalized expenditures are depleted over proven and probable reserves upon commencement of production using the units-of-production method. Where proven and probable reserves have not been established, such capitalized expenditures are depleted over the estimated production life upon commencement of extraction using the straight-line method.

13

The carrying values of the mineral rights are assessed for impairment by management on a quarterly basis or when indicators of impairment exist. Should management determine that these carrying values cannot be recovered, the unrecoverable amounts are written off against earnings. As of May 31, 2023 and 2022, the Company did not have any capitalized mineral rights.

Recent Accounting Pronouncements

All newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.

NOTE 4 – MINING RIGHTS

Snow White Mine located in San Bernardino County, CA – Deposit

On November 28, 2014 US Mining and Minerals Corporation entered into a Purchase Agreement in which it agreed to sell its fee simple property interest and certain mining claims to USMC. In contemplation of the Plan and Agreement of Reorganization, on December 1, 2014, USMC, assigned its rights and obligations under the Purchase Agreement to the Company pursuant to an Assignment of Purchase Agreement. As a result of the Assignment, the Company assumed the purchaser position under the Purchase Agreement. The Purchase Agreement involves the sale of approximately 280 acres of mining property containing 5 placer mining claims known as the Snow White Mine located near Barstow, California in San Bernardino County. The property is covered by a Conditional Use Permit allowing the mining of the property and a Plan of Operation and Reclamation Plan has been approved by San Bernardino County and Bureau of Land Management. An initial deposit of $50,000 was paid to the Company and held in escrow, and the Purchase Agreement required the payment of an additional $600,000 at the end of the escrow period. There was a delay in the original seller, Joseph Richard Matthewson, receiving a clear title to the property and a fully permitted project, both of which were conditions to the closing of the sale from US Mining and Minerals Corporation to the Company. In light of the foregoing, and the payment of an additional $25,000, the parties agreed to extend the closing. Due to delays in the Company securing the necessary funding to close the purchase of the Snow White Mine property, John Bremer, a shareholder and a director of the Company, paid $575,000 to acquire the property interest and mining claims on or about October 15, 2015. Mr. Bremer agreed to transfer title to the Company upon payment of $575,000 plus expenses to Mr. Bremer, however, the Company is under no obligation to do so. The mining claims require a minimum royalty payment of $3,500 per year to be made by the Company, which is paid by USMC.

On April 1, 2020, the Company entered into a purchase and sale agreement with the Bremer Family 1995 Living Trust (the “Trust”), pursuant to which the Company will purchase the Snow White Mine for $836,000 (the “Purchase Price”) from the Trust. The Purchase Price plus 5% interest is payable in full in cash at closing. On April 14, 2022, the agreement was amended to extend the closing date to April 14, 2023. On April 7, 2023 the agreement was further amended to extend the Closing Date to April 1, 2024.   

NOTE 5 – PROPERTY AND EQUIPMENT

Property and equipment consisted of the following at:

	May 31, 2023			November 30, 2022
Furniture and equipment	$	6,952		$	6,952
Machinery and equipment		35,151			35,151
Automobiles and trucks		25,061			25,061
Construction in process		620,000			620,000
		687,164			687,164
Less: accumulated depreciation		(67,164	)		(67,164	)
Property and equipment, net	$	620,000		$	620,000

There was no depreciation expense for the three or six months ended May 31, 2023 and 2022.

14

NOTE 6 – NOTES PAYABLE

Bayshore Capital Advisors, LLC

On February 26, 2016, the Company issued a promissory note to Bayshore Capital Advisors, LLC (“Bayshore Capital”), an affiliate through common ownership of a 10% major stockholder of the Company, for $25,000 for working capital at an interest rate of 6% per annum. The note was payable August 26, 2016, or when the Company closes a bridge financing, whichever occurs first. On February 4, 2023, Bayshore Capital agreed to cancel the $25,000 debt, plus $10,146 of accrued and unpaid interest. Prior to the cancellation of the note, the Company was in default on the note. Total interest expense on the note was $255 and $750 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on the note was zero and $380 for the three months ended May 31, 2023 and 2022.

A. Scott Dockter – President and Chief Executive Officer

On August 31, 2017, the Company issued a note in the amount of $197,096 to A. Scott Dockter, President, Chief Executive Officer and a director of the Company, to consolidate the total amounts due to Mr. Dockter. The note bears interest at 6% and is due upon demand. During the six months ended May 31, 2023, the Company paid $15,000 towards the outstanding balance of the note. Total interest expense on the note was $612 and $1,706 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on the note was $233 and $837 for the three months ended May 31, 2023 and 2022, respectively. The balance on the note was $13,716 and $28,716 as of May 31, 2023 and November 30, 2022, respectively. There was $41,779 and $41,167 of accrued interest as of May 31, 2023 and November 30, 2022, respectively.

Convertible Promissory Notes – USMC

December 1, 2019

On December 1, 2019, in connection with the September 26, 2019 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $20,000 to USMC, with a maturity date of December 31, 2021 (“Tranche #1”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock, at any time at the option of the holder, at a conversion price of $0.16 per share. On April 7, 2022, the December 1, 2019 note was amended to extend the maturity date to April 30, 2022 and USMC gave notice of conversion of the outstanding principal balance of $20,000 plus accrued interest totaling $2,351 through such date, into 139,692 shares of the Company’s common stock.

The issuance of Tranche #1 resulted in a discount from the beneficial conversion feature totaling $20,000. Total straight-line amortization of this discount was zero for the three and six months ended May 31, 2023 and May 31, 2022. Total interest expense on Tranche #1 was approximately zero and $350 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on Tranche #1 was approximately zero and $100 for the three months ended May 31, 2023 and 2022, respectively.

January 1, 2020

On January 1, 2020, in connection with the September 26, 2019 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $86,000 to USMC, with a maturity date of January 1, 2022 (“Tranche #2”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock, at any time at the option of the holder, at a conversion price of $0.16 per share. On April 7, 2022, the January 1, 2020 note was amended to extend the maturity date to April 30, 2022 and USMC gave notice of conversion of the outstanding principal balance of $86,000 plus accrued interest totaling $9,743 through such date, into 598,392 shares of the Company’s common stock.

15

The issuance of Tranche #2 resulted in a discount from the beneficial conversion feature totaling $32,250. Total straight-line amortization of this discount totaled zero and $1,412 for the three and six months ended May 31, 2023 and May 31, 2022, respectively. Total interest expense on Tranche #2 was approximately zero and $1,500 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on Tranche #2 was approximately zero and $450 for the three months ended May 31, 2023 and 2022, respectively.

February 1, 2020

On February 1, 2020, in connection with the September 26, 2019 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $72,000 to USMC, with a maturity date of February 1, 2022 (“Tranche #3”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock, at any time at the option of the holder, at a conversion price of $0.16 per share. On April 7, 2022, the February 1, 2020 note was amended to extend the maturity date to April 30, 2022 and USMC gave notice of conversion of the outstanding principal balance of $72,000 plus accrued interest totaling $7,851 through such date, into 499,068 shares of the Company’s common stock.

The issuance of Tranche #3 resulted in a discount from the beneficial conversion feature totaling $36,000. Total straight-line amortization of this discount totaled zero and $3,103 for the six months ended May 31, 2023 and May 31, 2022, respectively. Total interest expense on Tranche #3 was approximately zero and $1,260 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on Tranche #3 was approximately zero and $375 for the three months ended May 31, 2023 and 2022, respectively.

December 1, 2020

On December 1, 2020, in connection with the September 26, 2019 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $822,000 to USMC, with a maturity date of November 25, 2022 (“Tranche 4”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.16 per share. On April 7, 2022 USMC gave notice of conversion of the outstanding principal balance of $822,000 of the December 1, 2020 note, plus accrued interest totaling $55,401 through such date, into 5,483,753 shares of the Company’s common stock. Total interest expense on Tranche #4 was approximately zero and $17,700 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on Tranche #4 was approximately zero and $7,500 for the three months ended May 31, 2023 and 2022, respectively.

March 17, 2021

On March 17, 2021, in connection with the March 11, 2021 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $579,769 to USMC, with a maturity date of March 17, 2023 (“Tranche #5”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.088 per share. On April 7, 2022 USMC gave notice of conversion of the outstanding principal balance of $579,769.39 of the March 17, 2021 note, plus accrued interest totaling $30,656 through such date, into 6,936,656 shares of the Company’s common stock. Total interest expense on Tranche #5 was approximately zero and $8,800 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on Tranche #5 was approximately zero and $1,700 for the three months ended May 31, 2023 and 2022, respectively.

March 14, 2022

On March 14, 2022, in connection with the November 25, 2020 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $884,429 to USMC, with a maturity date of March 14, 2024 (“Tranche #6”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.088 per share. On April 7, 2022 USMC gave notice of conversion of the outstanding principal balance of $884,492 of the March 14, 2022 note, plus accrued interest totaling $2,908 through such date, into 10,084,093 shares of the Company’s common stock. Total interest expense on Tranche #6 was approximately zero and $2,908 for the six months ended May 31, 2023 and May 31, 2022. Total interest expense on Tranche #6 was approximately zero and $2,908 for the three months ended May 31, 2023 and May 31, 2022.

16

August 30, 2022

On August 30, 2022, in connection with the April 7, 2022 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $470,862 to USMC, with a maturity date of August 30, 2024 (“Tranche #7”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.39 per share. Total interest expense on Tranche #7 was $11,610 for the six months ended May 31, 2023. Total interest expense on Tranche #7 was $5,805 for the three months ended May 31, 2023.

November 29, 2022

On November 29, 2022, in connection with the April 7, 2022 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $140,027 to USMC, with a maturity date of August 30, 2024 (“Tranche #8”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.39 per share. Total interest expense on Tranche #8 was $3,453 for the six months ended May 31, 2023. Total interest expense on Tranche #8 was $1,726 for the three months ended May 31, 2023.

February 28, 2023

On February 28, 2023, in connection with the April 7, 2022 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $308,320 to USMC, with a maturity date of February 28, 2025 (“Tranche #9”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.39 per share. Total interest expense on Tranche #9 was $3,801 for the three and six months ended May 31, 2023.

May 31, 2023

On May 31, 2023, in connection with the March 20, 2023 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $412,533 to USMC, with a maturity date of May 31, 2025 (“Tranche #10”). The note bears interest at 8% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.10 per share. There was no interest expense on Tranche #10 for the three and six months ended May 31, 2023.

Line of Credit –USMC

July 10, 2023

On July 10, 2023 , the Company entered into a line of credit agreement and unsecured convertible grid promissory note with USMC. The July 10, 2023 line of credit agreement provides for the issuance for up to one year of up to an aggregate of $1,000,000 of advances from USMC under an unsecured convertible grid promissory note (See Note 12). The note bears interest at 8% annum and any outstanding principal or accrued interest under the note is convertible into shares of the Company’s common stock at a conversion price of $0.10 per share on the maturity date. As of the date hereof, there have been no advances from USMC under the July 10, 2023 line of credit agreement.

17

Convertible Debt – Board of Directors

On April 8, 2021, the Company entered into a twelve-month director agreement with Jeffrey Guzy, as amended on August 26, 2022 (the “Guzy Director Agreement”) pursuant to which Mr. Guzy will serve as a director of the Company, which agreement will automatically renew (the “Renewal Date”) for successive one-year terms unless either party notifies the other of its desire not to renew the Agreement within 30 days of the expiration of the then current term. As compensation therefor, Mr. Guzy is entitled to a cash fee of $1,000 per month which accrues as 0% debt to the Company until the Company has its first cash-flow positive month. Any amounts owed to Mr. Guzy at the Renewal Date or upon Mr. Guzy’ resignation or removal (the “Termination Date”) will be converted into the Company’s common stock at a price per share equal to the market price on the exchange or trading market where such stock is then traded or quoted or the volume-weighted average price (“VWAP”) of the common stock for the 20days immediately preceding the Renewal Date or the Termination Date, as the case may be. On April 14, 2023, Mr. Guzy converted $24,000 in accrued but unpaid director fees into 80,000 shares of common stock at $0.15 per share and 150,000 shares of common stock at $0.08 per share. As of May 31, 2023, cash fees owed to Mr. Guzy under the Guzy Director Agreement were deferred and debt in the amount of $2,000 is owed to Mr. Guzy.

On August 13, 2021, the Company entered into a twelve-month director agreement with Dr. Kurtis, as amended on August 26, 2022 (the “Kurtis Director Agreement”) pursuant to which Dr. Kurtis will provide up to five hours per month of board services, which agreement will automatically renew for successive one-year terms unless either party notifies the other of its desire not to renew the Agreement within 30 days of the expiration of the then current term. As compensation therefor, Dr. Kurtis is entitled to a cash fee of $1,000 per month which accrues as debt to the Company until the Company has its first cash-flow positive month. Any amounts owed to Dr. Kurtis at the Renewal Date or the Termination Date will be converted into common stock at a price per share equal to market price on the exchange or trading market where such stock is then traded or quoted or the VWAP of the common stock for the 20 days immediately preceding the Renewal Date or the Termination Date, as the case may be. On April 14, 2023, Dr. Kurtis exercised the conversion of $12,000 in accrued but unpaid director fees to purchase 80,000 shares of common stock at $0.15 per share. As of May 31, 2023, cash fees owed to Dr. Kurtis as per the terms of the Kurtis Director Agreement were deferred and debt in the amount of $10,000 is owed to Dr. Kurtis.

NOTE 7 – LEASES

The following table presents net lease cost and other supplemental lease information:

	Six Months Ended May 31, 2023
Lease cost
Operating lease cost (cost resulting from lease payments)	$	21,000
Short term lease cost		-
Sublease income		-
Net lease cost	$	21,000
Operating lease – operating cash flows (fixed payments)	$	21,000
Operating lease – operating cash flows (liability reduction)	$	19,197
Non-current leases – right of use assets	$	59,699
Current liabilities – operating lease liabilities	$	39,869
Non-current liabilities – operating lease liabilities	$	20,696

	Six Months Ended May 31,2022
Lease cost
Operating lease cost (cost resulting from lease payments)	$	9,000
Short term lease cost		-
Sublease income		-
Net lease cost	$	9,000
Operating lease – operating cash flows (fixed payments)	$	9,000
Operating lease – operating cash flows (liability reduction)	$	8,688
Non-current leases – right of use assets	$	7,109
Current liabilities – operating lease liabilities	$	7,407
Non-current liabilities – operating lease liabilities	$	-

18

Future minimum payments under non-cancelable leases for operating leases for the remaining terms of the leases following the three months ended May 31, 2023:

Fiscal Year	Operating Leases
Remainder of 2023	$	31,500
2024		31,500
Total future minimum lease payments		63,000
Amount representing interest		(2,435	)
Present value of net future minimum lease payments	$	60,565

NOTE 8 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consist of the following amounts as of:

	May 31, 2023		November 30, 2022
Accounts payable	$	316,496	$	30,078
Accrued interest – related party		66,595		57,266
Accrued compensation		29,466		28,134
Accounts payable and accrued expenses	$	412,557	$	115,478

NOTE 9 – COMMITMENTS AND CONTINGENCIES

Office and Rental Property Leases

The Company is leasing office space from USMC, a company that is owned by the Company’s majority shareholders and directors, A. Scott Dockter and John Bremer (See Note 12).

Mineral Properties

The Company’s mineral rights require various annual lease payments (See Note 4).

Legal Matters

On July 8, 2020, the Company’s former Chief Financial Officer, Al Calvanico (“Calvanico”), filed a demand for arbitration alleging retaliation, wrongful termination, and demand for a minimum of $600,000 in alleged stock value, plus interest, recovery of past and future wages, attorneys’ fees, and punitive damages (collectively, the “Calvanico Claims”). The Company denied all Calvanico Claims. The Company believes Calvanico is owed nothing because it takes the position that Calvanico was not terminated, but rather, his employment contract expired on September 21, 2019, in accordance with its terms, and was not renewed by the Company and because Calvanico never exercised his stock options. On February 14, 2020, the Company requested in writing that Calvanico exercise his stock options within 30 days. Calvanico failed to do so. The Company and Calvanico engaged in binding arbitration which concluded on February 3, 2023. On June 20, 2023, the arbitrator decided in favor of the Company with respect to breach of contract, fraud and negligent representation and wrongful discharge and in favor of Calvanico for attorneys’ fees for Calvanico’s asserted claims in accordance with his employment agreement with the Company. A teleconference was set for July 18, 2023 for determination of the amount of attorneys’ fees to be awarded.

19

On March 29, 2019, the Company was served with a complaint filed by Superior Soils Supplements LLC (“Superior Soils”) in the Superior Court of the State of California in and for the County of Kings (Case #19C-0124) relating to 64 truckloads of soil amendments delivered to a customer by the Company on behalf of Superior Soils. Superior Soils alleged that the soil amendments were not labeled correctly requiring the entire shipment of product to be returned to the Company. The complaint alleges breach of contract, misrepresentations, fraudulent concealment and unfair competition. The complaint sought damages of approximately $400,000 and, although the Company vigorously defended such claims and believed there was little to no risk of liability, it accrued $400,000 for such risk. On April 28, 2023, the Company and Superior Soils entered into a settlement agreement and mutual release pursuant to which the Company paid $125,000 to Superior Soils and Superior Soils filed a dismissal with prejudice.

Contractual Matters

On November 1, 2013, the Company entered into an agreement with USMC, in which USMC provides various technical evaluations and mine development services for the Company with regard to the various mining properties/rights owned by the Company. Terms of services and compensation will be determined for each project undertaken by USMC.

On October 12, 2018, the Company entered into a material supply agreement with USMC, pursuant to which USMC provides designated natural resources to the Company at predetermined prices (See Note 12).

Note 10 - STOCKHOLDERS’ EQUITY

On May 19, 2022, the Company entered into an agreement with Newbridge Securities Corporation (“Newbridge”) for a twelve-month term, pursuant to which Newbridge provided investment banking and corporate advisory services to the Company. As consideration therefor, the Company issued Newbridge 300,000 shares of common stock on June 17, 2022 which shares were subject to a 12-month lockup from the date of issuance. The shares were issued at a fair value of $0.35 per share.

On June 9, 2023, effective April 8, 2023, the Company entered into a one-year advisory agreement with Dr. Karen Scrivener (“Scrivener Agreement”) pursuant to which Dr. Scrivener will provide certain strategic decision advisory  services to the Company. As compensation therefor, Dr. Scrivener was issued 100,000 shares of the Company’s common stock on June 9, 2023 at $0.08 per share.

Note 11 – STOCK-BASED COMPENSATION

The Company accounted for its stock-based compensation in accordance with the fair value recognition provisions of FASB ASC Topic 718.

2017 Equity Incentive Plan

On November 10, 2017, the Board approved the 2017 PureBase Corporation Stock Option Plan which is intended to be a qualified stock option plan (the “Option Plan”). The Board reserved 10,000,000 shares of the Company’s common stock to be issued pursuant to options granted under the Option Plan. The Option Plan was subsequently approved by shareholders on September 28, 2018. As of May 31, 2023, options to purchase an aggregate of 128,688,187 shares of common stock have been granted under the Option Plan.

The Company has also granted options to purchase an aggregate of 500,000 shares of common stock pursuant to employment contracts with certain employees prior to the adoption of the Option Plan.

On June 3, 2022, in connection with the settlement agreement with Agregen, Robert Hurtado, James Todd Gauer and John Gingerich, the Company granted James Todd Gauer an immediately exercisable option to purchase 8,669,400 shares of common stock, the equivalent number of shares of common stock that were surrendered to the Company, at an exercise price of $2.50 per share and a fair value of $1,856,151. The option was valued using the Black-Scholes option pricing model under the assumptions in the below table.

20

On August 26, 2022, the Company granted immediately exercisable options to purchase an aggregate of 2,223,787 shares of common stock to members of the Board, consultants and employees for services to be performed. The options were issued at an exercise price of $0.24 per share and a total fair value of $522,411. The options were valued using the Black-Scholes option pricing model under the assumptions in the below table.

Grant Date	Number of Options		Stock Price		Exercise Price		Expected Volatility			Risk-free Interest Rate			Dividend Rate			Expected Term	Fair Value
4/8/2021		250,000	$	0.15	$	0.10		281.00	%		0.85	%		0.00	%	2.50 years	$	36,708
8/13/2021		200,000	$	0.46	$	0.36		266.00	%		0.79	%		0.00	%	3.50 years	$	90,944
10/6/2021		116,000,000	$	0.38	$	0.38		278.00	%		1.26	%		0.00	%	3.88 years	$	43,808,780
6/3/2022		8,669,400	$	0.22	$	2.50		274.50	%		2.95	%		0.00	%	3.50 years	$	1,856,151
8/26/2022		1,734,615	$	0.24	$	0.24		269.24	%		3.20	%		0.00	%	3.50 years	$	411,668
8/26/2022		242,424	$	0.24	$	0.24		276.76	%		3.20	%		0.00	%	3.00 years	$	57,264
8/26/2022		246,748	$	0.24	$	0.24		207.37	%		3.20	%		0.00	%	2.50 years	$	53,479

The Company did not grant stock options during the six months ended May 31, 2023 and May 31, 2022.

The weighted average non-vested grant date fair value of non-vested options was zero and $10,917,826 at May 31, 2023 and November 30, 2022, respectively.

Compensation based stock option activity for qualified and unqualified stock options are summarized as follows:

			Weighted
	Number of		Average
	Shares		Exercise Price
Outstanding at November 30, 2021		117,795,000	$	0.39
Granted		-		-
Exercised		-		-
Expired or cancelled		-		-
Outstanding at May 31, 2022		117,795,000	$	0.39
Outstanding at November 30, 2022		128,688,187	$	0.53
Granted		-		-
Exercised		-		-
Expired or cancelled		-		-
Outstanding at May 31, 2023		128,688,187	$	0.53

The following table summarizes information about options to purchase shares of the Company’s common stock outstanding and exercisable at May 31, 2023:

				Weighted-		Weighted-
				Average		Average
Exercise		Outstanding		Remaining Life		Exercise		Number
Price		Options		In Years		Price		Exercisable
$	0.10		400,000		1.39	$	0.10		400,000
	0.10		645,000		2.54		0.10		645,000
	0.12		50,000		5.57		0.12		50,000
	0.24		2,223,787		4.16		0.24		2,223,787
	0.36		200,000		3.45		0.36		200,000
	0.38		116,000,000		5.59		0.38		116,000,000
	2.50		8,669,400		4.26		2.50		8,669,400
	3.00		500,000		3.01		3.00		500,000
			128,688,187		5.44	$	0.53		128,688,187

The compensation expense attributed to the issuance of the options is recognized as options vest.

21

The stock options granted are exercisable over various terms from thee to ten years from the grant date and vest over various terms from the grant date to five years.

Total compensation expense related to the options was $7,326,402 and $18,254,083 for the six months ended May 31, 2023 and May 31, 2022, respectively. Total compensation expense related to the options was $1,841,389 and $7,304,345 for the three months ended May 31, 2023 and May 31, 2022, respectively. As of May 31, 2023, there was no future compensation cost related to non-vested stock options.

The aggregate intrinsic value is $31,155 for total outstanding and exercisable options, which was based on an estimated fair value of the Company’s common stock of $0.13 as of May 31, 2023, which is the aggregate fair value of the common stock that would have been received by the option holders had all option holders exercised their options as of that date, net of the aggregate exercise price.

NOTE 12 – RELATED PARTY TRANSACTIONS

Bayshore Capital Advisors, LLC

On February 26, 2016, the Company issued a promissory note to Bayshore Capital Advisors, LLC (“Bayshore Capital”), an affiliate through common ownership of a 10% major stockholder of the Company, for $25,000 for working capital at an interest rate of 6% per annum. The note was payable August 26, 2016, or when the Company closes a bridge financing, whichever occurs first. On February 4, 2023, Bayshore Capital agreed to cancel the $25,000 debt, plus $10,146 of accrued and unpaid interest. Prior to the cancellation of the note, the Company was in default on the note. Total interest expense on the note was $255 and $750 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on the note was zero and $380 for the three months ended May 31, 2023 and 2022, respectively.

US Mine Corporation

The Company entered into a contract mining agreement with USMC, a company which A. Scott Dockter, the Company’s Chief Executive Officer and a director, and John Bremer, a director, each own 33%, pursuant to which USMC provides various technical evaluations and mine development services to the Company. During the six months ended May 31, 2023 and 2022, the Company made $34,364 and no purchases from USMC, respectively. No services were rendered by USMC for the six months ended May 31, 2023 and 2022. In addition, during the six months ended May 31, 2023 and 2022, USMC paid $15,853 and $4,438, respectively, of expenses to the Company’s vendors and creditors on behalf of the Company. During the six months ended May 31, 2023 and 2022, USMC made cash advances to the Company of $705,000 and $410,000, respectively, which are recorded as part of due to affiliates and convertible notes payable, related party on the Company’s condensed consolidated balance sheets. All amounts owed for services rendered, expenses paid on behalf of the Company, and cash advances were converted into the Company’s common stock pursuant to the September 5, 2019 Debt Exchange Agreement, the November 25, 2020 Securities Purchase Agreement (See Note 6) and the April 7, 2022 Securities Purchase Agreement (See Note 6). The Company had a balance due of $406,604 and zero to USMC on May 31, 2023 and November 30, 2022, respectively.

USMC Notes

The Company has entered into various securities purchase agreements with USMC pursuant to which USMC may purchase the Company’s unsecured convertible promissory notes (See Note 6). The outstanding balance on the convertible notes due to USMC was $1,331,742 and $610,889 on May 31, 2023 and November 30, 2022, respectively. Interest expense on the convertible notes due to USMC totaled $18,864 and $32,518 for the six months ended May 31, 2023 and May 31, 2022, respectively. Interest expense on the convertible notes due to USMC totaled $11,333 and $13,033 for the three months ended May 31, 2023 and May 31, 2022, respectively.

22

USMC Line of Credit

On July 10, 2023, the Company entered into a line of credit agreement and unsecured convertible grid promissory note with USMC. The July 10, 2023 line of credit agreement provides for the issuance for up to one year of up to an aggregate of $1,000,000 of advances from USMC under an unsecured convertible grid promissory note (See Note 6). The note bears interest at 8% annum and any outstanding principal or accrued interest under the note is convertible into shares of the Company’s common stock at a conversion price of $0.10 per share on the maturity date. As of the date hereof, there have been no advances from USMC under the July 10, 2023 line of credit agreement.

USMC Mining Agreements

On April 22, 2020, the Company entered into a Material Supply Agreement (the “Supply Agreement”) with USMC which amended the prior Materials Supply Agreement entered into on October 12, 2018. Under the terms of the Supply Agreement, all kaolin clay purchased by the Company from USMC under the Supply Agreement must be used exclusively for agricultural products and supplementary cementitious materials. The Company will pay $25 per ton for the kaolin clay for supplementary cementitious materials and $145 per ton for bagged products for clay for agriculture (in each case plus an additional $5 royalty fee per ton). The Supply Agreement also provides that if USMC provides pricing to any other customer which is more favorable than that provided to the Company, USMC will adjust the cost to the Company to conform to the more favorable terms. The initial term of the Supply Agreement is three years, which automatically renews for three successive one-year terms, unless either party provides notice of termination at least sixty days prior to the end of the then current term. Either party has the right to terminate the Supply Agreement for a material breach which is not cured within 90 days. For the six months ended May 31, 2023 and 2022, the Company purchased $34,365 and $72,236, respectively, under the Supply Agreement. For the three months ended May 31, 2023 and 2022, the Company purchased $12,450 and $72,236, respectively, under the Supply Agreement. Since April 22, 2020, the Company has purchased $292,806 of materials under the Supply Agreement.

US Mine LLC

On May 27, 2021, the Company entered into the Materials Extraction Agreement with US Mine, LLC, pursuant to which the Company acquired the right to extract up to 100,000,000 of certain raw clay materials. The Materials Extraction Agreement is effective until 100,000,000 tons of material are extracted. As compensation for such right, the Company issued a ten-year convertible promissory note in the principal amount of $50,000,000 to US Mine, LLC (the “US Mine Note”). The US Mine Note bears interest at the rate of 2.5% per annum which is payable upon maturity. Amounts due under the US Mine Note may be converted into shares of the Company’s common stock at the option of the noteholder, at a conversion price of $0.43 per share. The noteholder may convert (i) up to 50% of the outstanding balance on or after such date as the Company’s common stock is listed for trading on any national securities exchange, (ii) up to an additional 25% of the outstanding balance on or after the six-month anniversary of such initial trading date, and (iii) the remaining 25% on or after the twelve-month anniversary of such initial trading date. In addition, the Company will pay US Mine, LLC a royalty fee of $5.00 per ton of materials extracted and any royalty not paid in a timely manner with be subject to 15% interest per annum and compounded monthly.

On October 6, 2021, and prior to consummation of activities under the Materials Extraction Agreement, the Company and US Mine, LLC executed an amendment to the Materials Extraction Agreement (the “Amendment”). Pursuant to the Amendment, the US Mine Note was retroactively rescinded, ab initio and an option to purchase an aggregate of 116,000,000 shares of the Company’s common stock at an exercise price of $0.38 per share until April 6, 2028, was issued to US Mine, LLC as compensation. Shares subject to the option vested as to 58,000,000 shares on April 6, 2022, 29,000,000 shares on October 6, 2022, and 29,000,000 shares on April 6, 2023. This agreement was further amended and restated on June 21, 2022, with the same option purchase, vesting and exercise schedule. For the three and six months ended May 31, 2023 the Company expensed $1,841,389 and $7,326,402 in stock-based compensation expense related to the issuance of the option on October 16, 2021 to US Mine LLC under the Materials Extraction Agreement.

23

Transactions with Officers

On August 31, 2017, the Company issued a note in the amount of $197,096 to A. Scott Dockter, President, Chief Executive Officer and a director of the Company, to consolidate the total amounts due to Mr. Dockter. The note bears interest at 6% and is due upon demand. During the six months ended May 31, 2023, the Company paid $15,000 towards the outstanding balance of the note. Total interest expense on the note was $612 and $1,706 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on the note was $233 and $837 for the three months ended May 31, 2023 and 2022, respectively. The balance on the note was $13,716 and $28,716 as of May 31, 2023 and November 30, 2022, respectively. There was $41,779 and $41,167 of accrued interest as of May 31, 2023 and November 30, 2022, respectively.

Convertible Debt – Board of Directors

On April 8, 2021, the Company entered into the Guzy Director Agreement (See Note 6) pursuant to which Mr. Guzy will serve as a director of the Company, which agreement will automatically renew for successive one-year terms unless either party notifies the other of its desire not to renew the Agreement within 30 days of the expiration of the then current term. As compensation therefor, Mr. Guzy is entitled to a cash fee of $1,000 per month which accrues as 0% debt to the Company until the Company has its first cash-flow positive month. Any amounts owed to Mr. Guzy at the Renewal Date or upon Mr. Guzy’ resignation or removal will be converted into common stock at a price per share equal to market price on the exchange or trading market where such stock is then traded or quoted or the VWAP of the common stock for the 20-days immediately preceding the Renewal Date or the Termination Date, as the case may be. The Agreement also includes a non-competition provision during the term of the Agreement and for twelve months thereafter.

On August 13, 2021, the Company entered into the Kurtis Director Agreement (See Note 6) pursuant to which Dr. Kurtis will provide up to five hours per month of board services, which agreement will automatically renew for successive one-year terms unless either party notifies the other of its desire not to renew the Agreement within 30 days of the expiration of the then current term. As compensation therefor, Dr. Kurtis is entitled to a cash fee of $1,000 per month which accrues as debt to the Company until the Company has its first cash-flow positive month. Any amounts owed to Dr. Kurtis at the Renewal Date or upon Dr. Kurtis’ resignation or removal will be converted into common stock at a price per share equal to market price on the exchange or trading market where such stock is then traded or quoted or the VWAP of the common stock for the 20-days immediately preceding the Renewal Date or the Termination Date, as the case may be. The Agreement includes a non-competition provision during the term of the Agreement and for twelve months thereafter.

On June 9, 2023, effective April 8, 2023, the Company entered into a one-year advisory agreement with Dr. Karen Scrivener (“Scrivener Agreement”) pursuant to which Dr. Scrivener will provide certain advisory services to the Company. As compensation therefor, Dr. Scrivener was issued 100,000 shares of the Company’s common stock on June 9, 2023 at $0.08 per share.

Leases

On October 1, 2020, the Company entered into a two-year lease agreement for its office space with USMC with a monthly rent of $1,500 (See Note 7). The lease was amended to extend the term for an additional two years to November 1, 2024 and to add an additional 700 square feet of office space for a total monthly rental price of $3,500 per month,

NOTE 13 – CONCENTRATION OF CREDIT RISK

Cash Deposits

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of May 31, 2023 and November 30, 2022, the Company had no deposits in excess of the FDIC insured limit.

24

Revenues

Three customers accounted for 99% of total revenue for the six months ended May 31, 2023, as set forth below:

Customer A	44	%
Customer B	40	%
Customer C	15	%

Three customers accounted for 100% of total revenue for the six months ended May 31, 2022, as set forth below:

Customer A	84	%
Customer B	8	%
Customer C	8	%

Accounts Receivable

Two customers accounted for 100% of the accounts receivable as of May 31, 2023, as set forth below:

Customer A	73	%
Customer B	27	%

There were no receivables as of November 30, 2022.

Vendors

One supplier accounted for 100% of purchases for the three months ended May 31, 2023.

Three suppliers accounted for 60% of purchases as of May 31, 2022, as set forth below:

Vendor A	31	%
Vendor B	16	%
Vendor C	13	%

NOTE 14 – SUBSEQUENT EVENTS

In accordance with ASC 855, Subsequent Events, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events and transactions that occurred after May 31, 2023 through the date the condensed consolidated financial statements were filed. During this period the Company did not have any material reportable subsequent events other than those stated below:

On July 10, 2023, the Company entered into a line of credit agreement and unsecured convertible grid promissory note with USMC. The July 10, 2023 line of credit agreement provides for the issuance for up to one year of up to an aggregate of $1,000,000 of advances from USMC under an unsecured convertible grid promissory note (See Note 12). The note bears interest at 8% annum and any outstanding principal or accrued interest under the note is convertible into shares of the Company’s common stock at a conversion price of $0.10 per share on the maturity date. As of the date hereof, there have been no advances from USMC under the July 10, 2023 line of credit agreement.

25

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q includes forward-looking statements that reflect management’s current views with respect to future events and financial performance. Forward-looking statements are statements in respect of future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. These statements include statements regarding the intent, belief or current expectations of our management team, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risk and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks set forth in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended November 30, 2022, as filed with the Securities and Exchange Commission (the “SEC”) on February 28, 2023, any of which may cause our company’s or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in our forward-looking statements. These risks and factors include, by way of example and without limitation:

● absence of contracts with customers or suppliers;

● our ability to maintain and develop relationships with customers and suppliers;

● the impact of competitive products and pricing;

● supply constraints or difficulties;

● the retention and availability of key personnel;

● general economic and business conditions;

● substantial doubt about our ability to continue as a going concern;

● our ability to successfully implement our business plan;

● our need to raise additional funds in the future;

● our ability to successfully recruit and retain qualified personnel in order to continue our operations;

● our ability to successfully acquire, develop or commercialize new products;

● the commercial success of our products;

● the impact of any industry regulation;

● our ability to develop existing mining projects or establish proven or probable reserves;

● our dependence on one vendor for our minerals for our products;

● the impact of potentially losing the rights to properties;

● the impact of the increase in the price of natural resources; and

● the continued impact of the COVID-19 pandemic.

We undertake no obligation to update or revise forward-looking statements to reflect events or circumstances occurring after the date of this Quarterly Report, except as required by law.

As used in this Quarterly Report and unless otherwise indicated, the terms “Company,” “we,” “us,” and “our,” refer to PureBase Corporation and its wholly-owned subsidiaries, PureBase Agricultural, Inc., a Nevada corporation (“PureBase AG”) and U.S. Agricultural Minerals, LLC, a Nevada limited liability company (“PureBase SCM”).

Business Overview

We are an industrial mineral and natural resource company that provides solutions to the agriculture and construction materials markets in the United States, through our two subsidiaries, PureBase AG, and PureBase SCM, respectively. The Company has not yet commenced mining operations and relies on US Mine LLC for its raw materials.

26

Agricultural Sector

We develop specialized fertilizers, sun protectants, soil amendments and bio-stimulants for organic and non-organic sustainable agriculture. We have developed and will seek to develop additional products derived from mineralized materials of leonardite, kaolin clay, laterite, and other natural minerals. These mineral and soil amendments are used to protect crops, plants and fruits from the sun and winter damage, to provide nutrients to plants, and to improve dormancy and soil ecology to help farmers increase the yields of their harvests. We are building a brand family under the parent trade name “PureBase,” consisting of its PureBase Shade Advantage WP product, a kaolin-clay based sun protectant for crops and Humic Advantage a humic acid product derived from leonardite.

Construction Sector

We are developing and testing a kaolin-based product that it believes will help create a lower CO2-emitting concrete through the use of high-quality supplementary cementitious materials (“SCMs”). We are developing SCMs for the construction material markets, particularly the cement markets that we believe can potentially replace up to 40% of cement, the most polluting part of concrete. As government agencies continue to enact stricter requirements for less-polluting forms of concrete, we believe there are significant opportunities for high-quality SCM products in the construction-materials sector.

We utilize the services of USMC, for the development and contract mining of industrial mineral and metal projects, exploration drilling, preparation of feasibility studies, mine modeling, on-site construction, production, site reclamation and for product fulfillment. Exploration services include securing necessary permits, environmental compliance, and reclamation plans. In addition, a substantial portion of the minerals used by the Company are obtained from properties owned or controlled by USMC.

A. Scott Dockter, the Company’s Chief Executive Officer and a director, and John Bremer, a director, are also officers, directors and owners of USMC.

Recent Developments

On July 10, 2023, the Company entered into a line of credit agreement and unsecured convertible grid promissory note with USMC. The July 10, 2023 line of credit agreement provides for the issuance for up to one year of up to an aggregate of $1,000,000 of advances from USMC under an unsecured convertible grid promissory note (See Note 12). The note bears interest at 8% annum and any outstanding principal or accrued interest under the note is convertible into shares of the Company’s common stock at a conversion price of $0.10 per share on the maturity date. As of the date hereof, there have been no advances from USMC under the July 10, 2023 line of credit agreement.

Results of Operations

Comparison of the Three Months Ended May 31, 2023 to the Three Months Ended May 31, 2022

	May 31, 2023			May 31, 2022			Variance
Revenue, net	$	66,376		$	228,476		$	(162,100	)
Cost of goods sold		26,606			88,030			(61,424	)
Operating income	$	39,770		$	140,446		$	(100,676	)
Operating Expenses:
Selling, general and administrative		2,321,585			7,622,810			(5,301,225	)
Loss from operations		(2,281,815	)		(7,482,364	)		5,200,549
Other income (expense)		275,000			-			275,000
Interest expense		(12,401	)		(11,013	)		1,388
Net Loss	$	(2,019,216	)	$	(7,493,377	)	$	5,474,161

27

Revenues

Revenue decreased by $162,100, or 71% for the three months ended May 31, 2023, as compared to the three months ended May 31, 2022. This decrease was primarily due to a decrease in purchases by the Company’s customers during the three months ended May 31, 2023.

Cost of Goods Sold

Cost of goods sold decreased by $61,424, or 70%, for the three months ended May 31, 2023, as compared to the three months ended May 31, 2022, directly corresponding with the decrease in revenue during the three months ended May 31, 2023.

Operating Expenses

Total operating expenses decreased by $5,301,225, or 70%, for the three months ended May 31, 2023, as compared to the three months ended May 31, 2022. The decrease in operating expenses was primarily due to a decrease in stock-based compensation of $5,462,956 for the three months ended May 31, 2023, as compared to the three months ended May 31, 2022.

The Company continued to expense the option to purchase an aggregate of 116,000,000 shares of common stock granted to US Mine LLC on October 6, 2021 through March 2023, which constituted 99% of stock-based compensation during the period. As of April,2023, the Company no longer expensed such option which resulted in a decreased stock-based compensation expense during the three months ended May 31, 2023 compared to the three months ended May 31, 2022.

Other Income

The increase in other income for the three months ended May 31, 2023, as compared to the three months ended May 31, 2022, is due to a recognized gain of $275,000 from the settlement with Superior Soils on April 28, 2023.

Interest Expense

Interest expense increased by $1,388 or 13%, for the three months ended May 31, 2023, as compared to the three months ended May 31, 2022, primarily due to a increase in outstanding debt.

28

Comparison of the Six Months Ended May 31, 2023 to the Six Months Ended May 31, 2022

	May 31, 2023			May 31, 2022			Variance
Revenue, net	$	118,632		$	228,476		$	(109,844	)
Cost of goods sold		49,069			91,282			(42,213	)
Operating income	$	69,563		$	137,194		$	(67,631	)
Operating Expenses:
Selling, general and administrative		8,208,455			18,823,211			(10,614,756	)
Loss from operations		(8,138,892	)		(18,868,017	)		10,547,125
Other income (expense)		310,401			2,007			308,394
Interest expense		(21,524	)		(31,911	)		10,387
Net Loss	$	(7,850,015	)	$	(18,715,921	)	$	10,865,906

Revenues

Revenue decreased by $109,844, or 48%, for the six months ended May 31, 2023, as compared to the six months ended May 31, 2022. This decrease was primarily due to a decrease in purchases by the Company’s customers during the six months ended May 31, 2023.

Cost of Goods Sold

Cost of goods sold expenses decreased by $42,213, or 46%, for the six months ended May 31, 2023, as compared to the six months ended May 31, 2022, directly corresponding with the decrease in revenue during the six months ended May 31, 2023.

Operating Expenses

Total operating expenses decreased by $10,614,756, or 56%, for the six months ended May 31, 2023, as compared to the six months ended May 31, 2022. The decrease in operating expenses was primarily due to a decrease in stock-based compensation of $10,927,681 for the six months ended May 31, 2023, as compared to the six months ended May 31, 2022.

The Company continued to expense the option to purchase an aggregate of 116,000,000 shares of common stock granted to US Mine LLC on October 6, 2021 through March 2023, which constituted 99% of stock-based compensation during the period. As of April, 2023, the Company no longer expensed such option which resulted in a decreased stock-based compensation expense during the six months ended May 31, 2023 compared to the six months ended May 31, 2022.

Other Income

Other income increased by $308,394 for the six months ended May 31, 2023, as compared to the six months ended May 31, 2022, primarily due to a gain on legal settlement of $275,000, and gain on forgiveness of debt and accrued interest in the amount of $35,401.

Interest Expense

Interest expense decreased by $10,387, or 33%, for the six months ended May 31, 2023, as compared to the six months ended May 31, 2022, primarily due to a decrease in outstanding debt.

29

Liquidity and Capital Resources

As of May 31, 2023, we had cash on hand of $23,248 and a working capital deficiency of $387,334, as compared to cash on hand of $19,055 and a working capital deficiency of $620,290 as of November 30, 2022. The decrease in working capital deficiency is primarily a result of a decrease in settlement liability from $400,000 to $225,000 and an increase in accounts receivable of $66,376, which were partially offset by an increase in accounts payable and accrued expenses of $297,079.

The Company’s operating activities consume the majority of its cash resources. The Company anticipates that it will continue to incur operating losses as it executes its development plans for 2023, as well as other potential strategic and business development initiatives. In addition, the Company has had and expects to have negative cash flows from operations, at least into the near future. The Company has previously funded, and plans to continue funding, these losses with cash advances from USMC and the sale of equity and convertible notes. The accompanying condensed consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.

Although no assurances can be given as to the Company’s ability to deliver on its revenue plans or that unforeseen expenses may arise, management currently believes that the revenue to be generated from operations together with equity and debt financing, including funding from USMC in connection with the March 23, 2022 securities purchase agreement, March 7, 2023 securities purchase agreement, and July 10, 2023 line of credit agreement will provide the necessary funding for the Company to continue as a going concern for the next twelve months.

On February 28, 2023, in connection with the securities purchase agreement with USMC, dated April 7, 2022, the Company issued a 5% convertible promissory note in the principal amount of $308,320 to USMC, which matures on February 28, 2025. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.39 per share.

On May 31, 2023, in connection with the securities purchase agreement with USMC, dated March 20, 2023, the Company issued an 8% convertible promissory note in the principal amount of $412,533 to USMC, which matures on May 31, 2025 Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.10 per share.

On July 10, 2023, the Company entered into a line of credit agreement and unsecured convertible grid promissory note with USMC. The July 10, 2023 line of credit agreement provides for the issuance for up to one year of up to an aggregate of $1,000,000 of advances from USMC under an unsecured convertible grid promissory note (See Note 12). The note bears interest at 8% annum and any outstanding principal or accrued interest under the note is convertible into shares of the Company’s common stock at a conversion price of $0.10 per share on the maturity date. As of the date hereof, there have been no advances from USMC under the July 10, 2023 line of credit agreement.

Going Concern

The unaudited condensed consolidated financial statements contained in this Quarterly Report on Form 10-Q have been prepared assuming that the Company will continue as a going concern. The Company has accumulated losses from inception through May 31, 2023 of $61,493,664 as well as negative cash flows from operating activities and a working capital deficiency. During the six months ended May 31, 2023, the Company received net cash proceeds of $705,000 from USMC and USMC paid $15,853 to vendors on behalf of the Company. If the Company does not generate additional revenue and obtain equity and debt financing from USMC or other third parties, it will not have sufficient cash to meet its obligations for the twelve months following the date of this Quarterly Report. There currently are no other arrangements or agreements for financing, and there can be no assurances that any other potential debt or equity financing will be available, or if available, on favorable terms. As such, these matters raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issue date of this report.

30

Working Capital Deficiency

	May 31, 2023			November 30, 2022
Current assets	$	90,808		$	23,786
Current liabilities		478,142			644,076
Working capital deficiency	$	(387,334	)	$	(620,290	)

The increase in current assets as of May 31, 2023 is primarily due to the increase of accounts receivable of $66,376. The decrease in current liabilities is primarily a result of a reduction in settlement liability from $400,000 to $225,000, partially offset by an increase in accounts payable and accrued expenses of $297,079.

Cash Flows

	Six Months Ended May 31,
	2023			2022
Net cash used in operating activities	$	(685,807	)	$	(425,780	)
Net cash provided by investing activities		-			-
Net cash provided by financing activities		690,000			400,000
Increase (decrease) in cash	$	4,193		$	(25,780	)

Operating Activities

Net cash used in operating activities was $685,807 for the six months ended May 31, 2023, primarily due to a net loss of $7,850,015, which primarily consisted of a non-cash expense of $7,326,402 related to stock-based compensation cost, professional fees of $542,885 and wages of $258,840, partially offset by a decrease of $275,000 in a settlement liability.

Net cash used in operating activities was $425,780 for the six months ended May 31, 2022, primarily due to a net loss of $18,715,921, which primarily consisted of a non-cash expense of $18,254,083 related to stock-based compensation cost, wages of $252,068 and professional fees of $239,529.

Investing Activities

There were no investing activities during the six months ended May 31, 2023 and May 31, 2022.

Financing Activities

For the six months ended May 31, 2022, net cash provided by financing activities was $690,000, consisting of $705,000 which was advanced to the Company by USMC and recorded as part of convertible notes payable, related party on the Company’s balance sheet. The advance was partially offset by $15,000 of principal payments to notes due to officers.

For the six months ended May 31, 2022, net cash provided by financing activities was $400,000, consisting of $410,000 which was advanced to the Company by USMC and recorded as part of convertible notes payable, related party on the Company’s balance sheet and a $10,000 principal payment to notes due to officers.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Critical Accounting Policies and Procedures

Our significant accounting policies are more fully described in Note 1 to our condensed consolidated financial statements included in this Quarterly Report and in our Annual Report on Form 10-K for the fiscal year ended November 30, 2022, as filed with the SEC on February 28, 2023.

31

Recently Adopted Accounting Pronouncements

Our recently adopted accounting pronouncements are more fully described in Note 3 to our unaudited condensed consolidated financial statements included in this Quarterly Report.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a smaller reporting company we are not required to provide the information required by this Item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as that term is defined in Rules 13a-15I and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures. In designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives.

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Report. Based upon that evaluation and subject to the foregoing, our principal executive officer and principal financial officer concluded that, our disclosure controls and procedures were not effective as of May 31, 2023 due to the material weaknesses in internal control over financial reporting described below.

Material Weaknesses in Internal Control over Financial Reporting

A material weakness, as defined in the standards established by Sarbanes-Oxley is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected on a timely basis.

The ineffectiveness of the Company’s internal control over financial reporting was due to the following material weaknesses:

● Inadequate segregation of duties consistent with control objectives;

● Lack of formal policies and procedures;

● Lack of risk assessment procedures on internal controls to detect financial reporting risks on a timely manner; and

● Lack of personnel with U.S. GAAP experience including a chief financial officer.

Management’s Plan to Remediate the Material Weakness

Management has been implementing and continues to implement measures designed to ensure that control deficiencies contributing to the material weakness are remediated, such that these controls are designed, implemented, and operating effectively. The remediation actions include:

● Continue to search for and evaluate qualified independent outside directors;

● Hiring a qualified chief financial officer before December 31, 2023;

● Identify gaps in the Company’s skills base and expertise required to meet the financial reporting requirements of a public company; and

● Continue to develop policies and procedures on internal control over financial reporting and monitor the effectiveness of operations on existing controls and procedures.

We have engaged a third-party financial operations consulting firm to assist with the preparation of SEC reporting.

Management will continue to monitor and evaluate the effectiveness of our internal controls and procedures over financial reporting on an ongoing basis and is committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal controls over financial reporting that occurred during the quarter ended May 31, 2023 that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

32

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

On July 8, 2020, the Company’s former Chief Financial Officer, Al Calvanico (“Calvanico”), filed a demand for arbitration alleging retaliation, wrongful termination, and demand for a minimum of $600,000 in alleged stock value, plus interest, recovery of past and future wages, attorneys’ fees, and punitive damages (collectively, the “Calvanico Claims”). The Company denied all Calvanico Claims. The Company believes Calvanico is owed nothing because it takes the position that Calvanico was not terminated, but rather, his employment contract expired on September 21, 2019, in accordance with its terms, and was not renewed by the Company and because Calvanico never exercised his stock options. On February 14, 2020, the Company requested in writing that Calvanico exercise his stock options within 30 days. Calvanico failed to do so. The Company and Calvanico engaged in binding arbitration which concluded on February 3, 2023. On June 20, 2023, the arbitrator decided in favor of the Company with respect to breach of contract, fraud and negligent representation and wrongful discharge and in favor of Calvanico for attorneys’ fees for Calvanico’s asserted claims in accordance with his employment agreement with the Company. A teleconference was set for July 18, 2023 for determination of the amount of attorneys’ fees to be awarded.

On March 29, 2019, the Company was served with a complaint filed by Superior Soils Supplements LLC (“Superior Soils”) in the Superior Court of the State of California in and for the County of Kings (Case #19C-0124) relating to 64 truckloads of soil amendments delivered to a customer by the Company on behalf of Superior Soils. Superior Soils alleged that the soil amendments were not labeled correctly requiring the entire shipment of product to be returned to the Company. The complaint alleges breach of contract, misrepresentations, fraudulent concealment and unfair competition. The complaint sought damages of approximately $400,000 and, although the Company vigorously defended such claims and believed there was little to no risk of liability, it accrued $400,000 for such risk. On April 28, 2023, the Company and Superior Soils entered into a settlement agreement and mutual release pursuant to which the Company paid $125,000 to Superior Soils and Superior Soils filed a dismissal with prejudice.

ITEM 1A. RISK FACTORS

As a smaller reporting company we are not required to provide the information required by this Item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES

There were no sales of equity securities during the period covered by this Report that were not registered under the Securities Act and were not previously reported in a Current Report on Form 8-K filed by the Company other than those noted below.

On April 14, 2023, Jeffrey Guzy, a director, converted $24,000 in accrued but unpaid director fees into 80,000 shares of common stock at $0.15 per share and 150,000 shares of common stock at $0.08 per share.

On April 14, 2023, Dr. Kimberly Kurtis, a director, converted $12,000 in accrued but unpaid director fees into 80,000 shares of common stock at $0.15 per share.

The above issuances did not involve any underwriters, underwriting discounts or commissions, or any public offering and we believe are exempt from the registration requirements of the Securities Act of 1933 by virtue of Section 4(2) thereof.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

None.

33

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibit Number	Description
31*	Section 302 Certification under the Sarbanes-Oxley Act of 2002 of the Chief Executive Officer and Chief Financial Officer
32*	Section 906 Certification under the Sarbanes-Oxley Act of 2002 of the Chief Executive Officer and the Chief Financial Officer
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

34

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

PUREBASE CORPORATION
By:	/s/ A. Scott Dockter
A. Scott Dockter
Chief Executive Officer and Chief Financial Officer
(Principal Executive Officer and Principal Financial and Accounting Officer)
Date: July 14, 2023

35

EX-31

Exhibit 31

PUREBASE CORPORATION

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, A. Scott Dockter, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of PureBase Corporation;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ A. Scott Dockter
A. Scott Dockter
Chief Executive Officer and Chief Financial Officer
(Principal Executive Officer and Principal Financial and Accounting Officer)
Date: July 14, 2023

EX-32

Exhibit 32

PUREBASE CORPORATION

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report on Form 10-Q of PureBase Corporation as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the registrant.

By:	/s/ A. Scott Dockter
A. Scott Dockter
Chief Executive Officer and Chief Financial Officer
(Principal Executive Officer and Principal Financial and Accounting Officer)
Date: July 14, 2023

XML

Cover - shares	6 Months Ended
	May 31, 2023	Jul. 14, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	May 31, 2023
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--11-30
Entity File Number	000-55517
Entity Registrant Name	PUREBASE CORPORATION
Entity Central Index Key	0001575858
Entity Tax Identification Number	27-2060863
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	8631 State Highway 124
Entity Address, City or Town	Ione
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95640
City Area Code	(209)
Local Phone Number	274-9143
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		230,863,005

XML

Condensed Consolidated Balance Sheets - USD ($)	May 31, 2023	Nov. 30, 2022
Current Assets:
Cash and cash equivalents	$ 23,248	$ 19,055
Accounts receivable	66,376
Prepaid expenses and other assets	1,184	4,731
Total Current Assets	90,808	23,786
Property and equipment, net	620,000	620,000
Right of use asset	59,699	79,599
Total Assets	770,507	723,385
Current Liabilities:
Accounts payable and accrued expenses	412,557	115,478
Settlement liability		400,000
Lease liability, current	39,869	38,882
Convertible notes payable, related party	12,000	36,000
Total Current Liabilities	478,142	644,076
Lease liability, net of current portion	20,696	40,880
Convertible notes payable; related party, net of current portion	1,331,742	610,889
Total Liabilities	1,830,580	1,295,845
Stockholders’ Deficit:
Common stock, $0.001 par value; 520,000,000 shares authorized; 230,763,005 and 230,753,005 shares issued and outstanding, at May 31, 2023 and November 30, 2022, respectively	160,360	160,350
Additional paid in capital	60,273,231	52,910,839
Accumulated deficit	(61,493,664)	(53,643,649)
Total Stockholders’ Deficit	(1,060,073)	(572,460)
Total Liabilities and Stockholders’ Deficit	770,507	723,385
Officer [Member]
Current Liabilities:
Notes payable	13,716	28,716
Related Party [Member]
Current Liabilities:
Notes payable		$ 25,000

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	May 31, 2023	Nov. 30, 2022
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common Stock, shares authorized	520,000,000	520,000,000
Common Stock, shares issued	230,763,005	230,753,005
Common Stock, shares outstanding	230,763,005	230,753,005

XML

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022
Income Statement [Abstract]
Revenue, net	$ 66,376	$ 228,476	$ 118,632	$ 228,476
Cost of goods sold	26,606	88,030	49,069	91,282
Operating Income	39,770	140,446	69,563	137,194
Operating Expenses:
Selling, general and administrative	2,321,585	7,622,810	8,208,455	18,823,211
Total Operating Expenses	2,321,585	7,622,810	8,208,455	18,823,211
Loss From Operations	(2,281,815)	(7,482,364)	(8,138,892)	(18,686,017)
Other Income (Expense):
Other income	275,000		310,401	2,007
Interest expense	(12,401)	(11,013)	(21,524)	(31,911)
Total Other Income (Expense), net	262,599	(11,013)	288,877	(29,904)
Net Loss	$ (2,019,216)	$ (7,493,377)	$ (7,850,015)	$ (18,715,921)
Loss per Common Share - Basic and Diluted	$ (0.01)	$ (0.03)	$ (0.03)	$ (0.08)
Weighted Average Shares Outstanding - Basic and Diluted	230,473,222	229,316,070	230,609,928	222,424,978

XML

Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Nov. 30, 2021		$ 144,977	$ 18,730,863	$ (21,061,224)	$ (2,185,384)
Beginning balance, shares at Nov. 30, 2021		215,380,751
Stock based compensation - shares			10,949,738		10,949,738
Net loss				(11,222,544)	(11,222,544)
Ending balance, value at Feb. 28, 2022		$ 144,977	29,680,601	(32,283,768)	(2,458,190)
Beginning balance, shares at Feb. 28, 2022		215,380,751
Beginning balance, value at Nov. 30, 2021		$ 144,977	18,730,863	(21,061,224)	(2,185,384)
Beginning balance, shares at Nov. 30, 2021		215,380,751
Net loss					(18,715,921)
Ending balance, value at May. 31, 2022		$ 168,719	39,534,375	(39,777,146)	(74,052)
Beginning balance, shares at May. 31, 2022		239,122,406
Beginning balance, value at Feb. 28, 2022		$ 144,977	29,680,601	(32,283,768)	(2,458,190)
Beginning balance, shares at Feb. 28, 2022		215,380,751
Stock based compensation - shares			7,304,345		7,304,345
Net loss				(7,493,377)	(7,493,377)
Convertible debt converted into common stock		$ 23,742	2,549,429		2,573,171
Beginning balance, shares		23,741,655
Ending balance, value at May. 31, 2022		$ 168,719	39,534,375	(39,777,146)	(74,052)
Beginning balance, shares at May. 31, 2022		239,122,406
Beginning balance, value at Nov. 30, 2022		$ 160,350	52,910,839	(53,643,649)	(572,460)
Beginning balance, shares at Nov. 30, 2022		230,753,005
Stock based compensation - shares			5,485,013		5,485,013
Net loss				(5,830,799)	(5,830,799)
Settlement share surrender		$ (300)	300
Beginning balance, shares		(300,000)
Ending balance, value at Feb. 28, 2023		$ 160,050	58,396,152	(59,474,448)	(918,246)
Beginning balance, shares at Feb. 28, 2023		230,453,005
Beginning balance, value at Nov. 30, 2022		$ 160,350	52,910,839	(53,643,649)	(572,460)
Beginning balance, shares at Nov. 30, 2022		230,753,005
Net loss					(7,850,015)
Ending balance, value at May. 31, 2023		$ 160,360	60,273,231	(61,493,664)	(1,060,073)
Beginning balance, shares at May. 31, 2023		230,763,005
Beginning balance, value at Feb. 28, 2023		$ 160,050	58,396,152	(59,474,448)	(918,246)
Beginning balance, shares at Feb. 28, 2023		230,453,005
Stock based compensation - shares			1,841,389		1,841,389
Net loss				(2,019,216)	(2,019,216)
Conversion of board of director accrued debt		$ 310	35,690		36,000
Beginning balance, shares		310,000
Ending balance, value at May. 31, 2023		$ 160,360	$ 60,273,231	$ (61,493,664)	$ (1,060,073)
Beginning balance, shares at May. 31, 2023		230,763,005

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	May 31, 2023	May 31, 2022
Cash Flows From Operating Activities:
Net loss	$ (7,850,015)	$ (18,715,921)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation	7,326,402	18,254,083
Amortization of debt discount		5,329
Non-cash director compensation	12,000
Gain on debt forgiveness	(35,401)
Gain on settlement	(275,000)
Changes in operating assets and liabilities:
Accounts receivable	(66,376)	(35,696)
Prepaid expenses and other assets	3,547	3,446
Right of use asset	19,900
Accounts payable and accrued expenses	323,333	62,979
Settlement liability	(125,000)
Change in settlement liability	(19,197)
Net Cash Used In Operating Activities	(685,807)	(425,780)
Cash Flows From Financing Activities:
Advances from related party	705,000	410,000
Payments on notes payable, related party	(15,000)	(10,000)
Net Cash Provided By Financing Activities	690,000	400,000
Net Increase (Decrease) In Cash and Cash Equivalents	4,193	(25,780)
Cash and Cash Equivalents - Beginning of Period	19,055	132,309
Cash and Cash Equivalents - End of Period	23,248	106,529
Noncash operating and financing activities:
Forgiveness of accounts payable due to USMC	(15,853)
Vendors paid for on behalf of the Company by USMC	8,320	4,282
Expenses paid for on behalf of the Company by USMC	7,533
Due to affiliates exchanged for convertible debt		884,493
Convertible debt converted to common stock		2,464,262
Accrued interest converted to common stock		108,909
Director compensation - accrued as convertible debt converted to common stock	$ 36,000

XML

ORGANIZATION AND BUSINESS OPERATIONS

6 Months Ended

May 31, 2023

Accounting Policies [Abstract]

ORGANIZATION AND BUSINESS OPERATIONS

NOTE 1 – ORGANIZATION AND BUSINESS OPERATIONS

Corporate Overview

PureBase Corporation (“PureBase” or the “Company”) was incorporated in the State of Nevada on March 2, 2010. The Company is an industrial mineral and natural resource company that provides solutions to the agriculture and construction materials markets in the United States through its two subsidiaries, PureBase Agricultural, Inc., a Nevada corporation (“PureBase AG”), and U.S. Agricultural Minerals, LLC, a Nevada limited liability company (“PureBase SCM”), respectively.

The Company is headquartered in Ione, California.

Agricultural Sector

The Company develops specialized fertilizers, sun protectants, soil amendments and bio-stimulants for organic and non-organic sustainable agriculture. The Company has developed and will seek to develop additional products derived from mineralized materials of leonardite, kaolin clay, laterite, and other natural minerals. These mineral and soil amendments are used to protect crops, plants and fruits from the sun and winter damage, to provide nutrients to plants, and to improve dormancy and soil ecology to help farmers increase the yields of their harvests. The Company is building a brand family under the parent trade name “PureBase,” consisting of its PureBase Shade Advantage (WP) product, a kaolin-clay based sun protectant for crops and Humic Advantage, a humic acid product derived from leonardite.

Construction Sector

The Company has been developing and testing a kaolin-based product that it believes will help create a lower CO2-emitting concrete through the use of high-quality supplementary cementitious materials (“SCMs”). The Company is developing an SCM that it believes can potentially replace up to 40% of cement, the most polluting part of concrete. As government agencies continue to enact stricter requirements for less-polluting forms of concrete, the Company believes there are significant opportunities for high-quality SCM products in the construction-materials sector.

The Company utilizes the services of US Mine Corporation (“USMC”), a Nevada corporation and a significant shareholder of the Company, for the development and contract mining of industrial mineral and metal projects, exploration drilling, preparation of feasibility studies, mine modeling, on-site construction, production, site reclamation, and product fulfillment. Exploration services include securing necessary permits, environmental compliance, and reclamation plans. In addition, a substantial portion of the minerals used by the Company are obtained from properties owned or controlled by USMC. A. Scott Dockter, the Company’s Principal Executive Officer and a director, and John Bremer, a director, are also officers, directors, and owners of USMC.

XML

GOING CONCERN AND LIQUIDITY

6 Months Ended

May 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

GOING CONCERN AND LIQUIDITY

NOTE 2 – GOING CONCERN AND LIQUIDITY

The accompanying condensed consolidated financial statements have been prepared on the basis that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. As of May 31, 2023, the Company had a significant accumulated deficit of $61,493,664 and working capital deficit of $387,334. For the six months ended May 31, 2023, the Company had a loss from operations of $8,138,892 and negative cash flows from operations of $685,807. The Company’s operating activities consume the majority of its cash resources. The Company anticipates that it will continue to incur operating losses as it executes its development plans for 2023. In addition, the Company has had and expects to have negative cash flows from operations, at least into the near future. The Company has previously funded, and plans to continue funding, these losses primarily with additional infusions of cash from advances from USMC and the sale of equity and convertible notes. The accompanying condensed consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.

The Company’s plan, through the continued promotion of its products to existing and potential customers, is to generate sufficient revenues to cover its anticipated expenses. The Company is currently exploring several options to meet its short-term cash requirements, including future line of credits and issuances of equity securities or equity-linked securities to USMC and other third parties.

Although no assurances can be given as to the Company’s ability to deliver on its revenue plans or that unforeseen expenses may arise, management currently believes that the revenue to be generated from operations together with equity and debt financing, including funding from USMC in connection with the March 23, 2022 securities purchase agreement, March 7, 2023 securities purchase agreement, and July 10, 2023 line of credit agreement will provide the necessary funding for the Company to continue as a going concern for the next twelve months. The March 23, 2022 securities purchase agreement provides for the issuance by the Company of up to an aggregate of $1,000,000 of two-year convertible promissory notes to USMC (See Note 6). The notes bear interest at 5% per annum and any outstanding principal or interest under the notes are convertible into shares of the Company’s common stock, at any time at the option of the holder, at a conversion price of $0.39 per share. Currently, the Company has issued $919,209 of convertible notes under the March 23, 2022 securities purchase agreement and may issue an additional $80,791 of convertible notes. The March 7, 2023 securities purchase agreement provides for the issuance by the Company of up to an aggregate of $1,000,000 of two-year convertible promissory notes to USMC (See Note 6). The notes bear interest at 8% per annum and any outstanding principal or interest under the notes are convertible into shares of the Company’s common stock, at any time at the option of the holder, at a conversion price of $0.10 per share. Currently, the Company has issued $412,533 of convertible notes under the March 7, 2023 securities purchase agreement and may issue an additional $587,467 of convertible notes under such agreement. The July 10, 2023 line of credit agreement provides for the issuance for up to one year of up to an aggregate of $1,000,000 of advances from USMC under an unsecured convertible grid promissory note (See Note 12). The note bears interest at 8% annum and any outstanding principal or accrued interest under the note is convertible into shares of the Company’s common stock at a conversion price of $0.10 per share on the maturity date. As of the date hereof, there have been no advances from USMC under the July 10, 2023 line of credit agreement. There currently are no other arrangements or agreements for financing, and management cannot guarantee any other potential debt or equity financing will be available, or if available, on favorable terms. As such, these matters raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date of this report. If adequate funds are not available on acceptable terms, or at all, the Company will need to curtail operations, or cease its operations completely.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

May 31, 2023

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) including Form 10-Q and Regulation S-X. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments, unless otherwise indicated) which are, in the opinion of management, necessary to fairly state the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been omitted pursuant to such rules and regulations. These financial statements and the information included under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read in conjunction with the audited financial statements and notes thereto for the year ended November 30, 2022 in our Annual Report on Form 10-K filed on February 28, 2023 with the SEC. The results of the six months ended May 31, 2023 (unaudited) are not necessarily indicative of the results to be expected for the full year ending November 30, 2023.

Principles of Consolidation

These condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries PureBase AG and PureBase SCM. Intercompany accounts and transactions have been eliminated upon consolidation.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and equity-based transactions at the date of the financial statements and the revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the condensed consolidated financial statements. Significant estimates include the useful lives of property and equipment, deferred tax asset and valuation allowance, and assumptions used in the Black-Scholes valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.

Revenue

The Company accounts for revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers. The Company derives revenues from the sale of products from its agricultural sector and construction sector. The Company’s contracted transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The Company’s contracts have a single performance obligation which are not separately identifiable from other promises in the contracts and is, therefore, not distinct. The Company’s performance obligation is satisfied upon the transfer of risk of loss to the customer.

Practical Expedients

As part of ASC Topic 606, the Company has adopted several practical expedients including:

● Significant Financing Component – the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to the customer and when the customer pays for that good or service will be one year or less.

● Unsatisfied and Partially Unsatisfied Performance Obligations – for all performance obligations related to contracts with a duration for less than one year, the Company has elected to apply the optional exemption provided in ASC Topic 606 and therefore is not required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially satisfied at the end of the reporting period.

● Shipping and Handling Activities – the Company elected to account for shipping and handling activities as a fulfillment cost rather than as a separate performance obligation.

● Right to Invoice – the Company has a right to consideration from a customer in an amount that corresponds directly with the value provided to the customer of the Company’s performance completed to date. The Company may recognize revenue in the amount to which the entity has a right to invoice.

Disaggregated Revenue

Revenue consists of the following by product offering for the six months ended May 31, 2023:

CROP WHITE II		SHADE ADVANTAGE (WP)		SulFe Hume Si ADVANTAGE		Total
$	-	$	67,152	$	51,480	$	118,632

Revenue consists of the following by product offering for the six months ended May 31, 2022:

CROP WHITE II		SHADE ADVANTAGE (WP)		SulFe Hume Si ADVANTAGE		Total
$	192,780	$	35,696	$	-	$	228,476

Cash and Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. There were no cash equivalents as of May 31, 2023 and November 30, 2022.

Accounts Receivable

The Company periodically assesses its accounts and other receivables for collectability on a specific identification basis. If collectability of an account becomes unlikely, an allowance is recorded for that doubtful account. As of May 31, 2023 and November 30, 2022, the Company has determined that no allowance for doubtful accounts was necessary.

Property and Equipment

 Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, generally three to five years. Expenditures that enhance the useful lives of the assets are capitalized and depreciated.

Equipment	3-5 years
Autos and trucks	5 years

Maintenance and repairs are charged to expense as incurred. At the time of retirement or other disposition of property and equipment, the cost and accumulated depreciation will be removed from the accounts and the resulting gain or loss, if any, will be reflected in operations. The Company currently has $620,000 in property and equipment, primarily two ball mills, acquired on May 1, 2020. As of May 31, 2023, the Company has not put the acquired property and equipment to use. As such, the Company has not recorded depreciation related to these assets.

Impairment of Long-Lived Assets

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of these assets is determined by comparing the forecasted undiscounted net cash flows of the operation to which the assets relate to the carrying amount. If the operation is determined to be unable to recover the carrying amount of its assets, then these assets are written down first, followed by other long-lived assets of the operation to fair value. Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets. No impairment losses were recorded during the three and six months ended May 31, 2023 and May 31, 2022.

Shipping and Handling

The Company incurs shipping and handling costs which are charged back to the customer. The Company did not incur shipping and handling costs during the three months ended May 31, 2023 and 2022, respectively. The Company incurred shipping and handling costs of $2,000 and no shipping and handling costs during the six months ended May 31, 2023 and 2022, respectively.

Advertising and Marketing Costs

The Company expenses advertising and marketing costs as incurred and such costs are recorded in selling, general and administrative expenses in the accompanying condensed consolidated statements of operations. Advertising and marketing expenses were $2,643 for the three and six months ended May 31, 2023. There were no advertising and marketing expenses for the three and six months ended May 31, 2022.

Fair Value Measurements

As defined in ASC 820, Fair Value Measurements and Disclosures, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.

Level 1:	Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
Level 2:	Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.
Level 3:	Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

Fair Value of Financial Instruments

The carrying value of cash, accounts receivable, accounts payable, and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amount of notes approximates the estimated fair value for these financial instruments as management believes that such notes constitute substantially all of the Company’s debt and interest payable on the notes based on the Company’s incremental borrowing rate.

Loss Per Common Share

Net loss per share of common stock is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the three and six month periods ended May 31, 2023 and 2022. All outstanding options are considered potential common stock. The dilutive effect, if any, of stock options are calculated using the treasury stock method. All outstanding convertible notes are considered common stock at the beginning of the period or at the time of issuance, if later, pursuant to the if-converted method. Since the effect of common stock equivalents is anti-dilutive with respect to losses, outstanding options have been excluded from the Company’s computation of net loss per share of common stock for the three and six months ended May 31, 2023 and May 31, 2022.

The following table summarizes the stocks that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive due to the Company’s net loss position even though the exercise price could be less than the average market price of the common stock:

	Three Months Ended,
	May 31, 2023		May 31, 2022
Convertible Notes		6,656,110		-
Stock Options		128,688,187		1,595,000
Total		135,344,297		1,595,000

	Six Months Ended,
	May 31, 2023		May 31, 2022
Convertible Notes		6,656,110		-
Stock Options		128,688,187		59,595,000
Total		135,344,297		59,595,000

Stock-Based Compensation

The Company applies the provisions of ASC 718, Compensation—Stock Compensation (“ASC 718”), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees, including employee stock options, in the accompanying condensed consolidated statements of operations.

For stock options issued to employees and members of the Company’s Board of Directors (the “Board”) for their services, the Company estimates the grant date fair value of each option using the Black-Scholes option pricing model. The use of the Black-Scholes option pricing model requires management to make assumptions with respect to the expected term of the option, the expected volatility of the common stock consistent with the expected life of the option, risk-free interest rates and expected dividend yields of the common stock. For awards subject to service-based vesting conditions, including those with a graded vesting schedule, the Company recognizes stock-based compensation expense equal to the grant date fair value of stock options on a straight-line basis over the requisite service period, which is generally the vesting term. Forfeitures are recorded as they are incurred as opposed to being estimated at the time of grant and revised.

Pursuant to ASU 2018-07 Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, the Company accounts for stock options issued to non-employees for their services in accordance with ASC 718. The Company uses valuation methods and assumptions to value the stock options that are in line with the process for valuing employee stock options as noted above.

Leases

With the adoption of ASC 842, Leases, operating lease agreements are required to be recognized on the balance sheet as Right-of-Use (“ROU”) assets and corresponding lease liabilities. ROU assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The lease terms may include options to extend or terminate the lease if it is reasonably certain that the Company will exercise that option.

The Company leases its corporate offices. All of the leases are classified as operating leases. The Company is a party to a two-year lease with USMC for 1,000 square feet of office space located in Ione, California (the “Ione Lease”) with respect to its corporate operations (See Note 7). Effective November 1, 2022, the Ione Lease was amended to extend the lease through October 2024 and to add an additional 700 square feet of office space for a total monthly rental price of $3,500 per month, with automatic one-month renewals. The remaining weighted average term is 1.4 years. The Company discounted lease payments using its estimated incremental borrowing rate at December 1, 2020. The weighted average incremental borrowing rate applied was 5%.

In accordance with ASC 842, the Company recognized a ROU asset and corresponding lease liability on the condensed consolidated balance sheet for long-term office leases. See Note 7 – Leases for further discussion, including the impact on the accompanying unaudited condensed consolidated financial statements and related disclosures.

Income Taxes

Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the condensed consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.

The Company utilizes ASC 740, Income Taxes, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the condensed consolidated financial statements or tax returns. The Company accounts for income taxes using the asset and liability method to compute the differences between the tax basis of assets and liabilities and the related financial amounts, using currently enacted tax rates. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

For uncertain tax positions that meet a “more likely than not” threshold, the Company recognizes the benefit of uncertain tax positions in the condensed consolidated financial statements. The Company’s practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in the condensed consolidated statements of operations.

Exploration Stage

In accordance with U.S. GAAP, expenditures relating to the acquisition of mineral rights are initially capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time as the Company exits the exploration stage by establishing proven or probable reserves. Expenditures relating to exploration activities such as drill programs to establish mineralized materials are expensed as incurred. Expenditures relating to pre-extraction activities are expensed as incurred until such time proven or probable reserves are established for that project, after which expenditures relating to mine development activities for that particular project are capitalized as incurred. As of May 31, 2023, the Company was not engaged in any mine exploration.

Mineral Rights

Acquisition costs of mineral rights are capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time as the Company exits the exploration stage by establishing proven or probable reserves, as defined by the SEC under Industry Guide 7, through the completion of a “final” or “bankable” feasibility study. Expenditures relating to exploration activities are expensed as incurred and expenditures relating to pre-extraction activities are expensed as incurred until such time proven or probable reserves are established for that project, after which subsequent expenditures relating to development activities for that particular project are capitalized as incurred.

Where proven and probable reserves have been established, the project’s capitalized expenditures are depleted over proven and probable reserves upon commencement of production using the units-of-production method. Where proven and probable reserves have not been established, such capitalized expenditures are depleted over the estimated production life upon commencement of extraction using the straight-line method.

The carrying values of the mineral rights are assessed for impairment by management on a quarterly basis or when indicators of impairment exist. Should management determine that these carrying values cannot be recovered, the unrecoverable amounts are written off against earnings. As of May 31, 2023 and 2022, the Company did not have any capitalized mineral rights.

Recent Accounting Pronouncements

All newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.

XML

MINING RIGHTS

6 Months Ended

May 31, 2023

Extractive Industries [Abstract]

MINING RIGHTS

NOTE 4 – MINING RIGHTS

Snow White Mine located in San Bernardino County, CA – Deposit

On November 28, 2014 US Mining and Minerals Corporation entered into a Purchase Agreement in which it agreed to sell its fee simple property interest and certain mining claims to USMC. In contemplation of the Plan and Agreement of Reorganization, on December 1, 2014, USMC, assigned its rights and obligations under the Purchase Agreement to the Company pursuant to an Assignment of Purchase Agreement. As a result of the Assignment, the Company assumed the purchaser position under the Purchase Agreement. The Purchase Agreement involves the sale of approximately 280 acres of mining property containing 5 placer mining claims known as the Snow White Mine located near Barstow, California in San Bernardino County. The property is covered by a Conditional Use Permit allowing the mining of the property and a Plan of Operation and Reclamation Plan has been approved by San Bernardino County and Bureau of Land Management. An initial deposit of $50,000 was paid to the Company and held in escrow, and the Purchase Agreement required the payment of an additional $600,000 at the end of the escrow period. There was a delay in the original seller, Joseph Richard Matthewson, receiving a clear title to the property and a fully permitted project, both of which were conditions to the closing of the sale from US Mining and Minerals Corporation to the Company. In light of the foregoing, and the payment of an additional $25,000, the parties agreed to extend the closing. Due to delays in the Company securing the necessary funding to close the purchase of the Snow White Mine property, John Bremer, a shareholder and a director of the Company, paid $575,000 to acquire the property interest and mining claims on or about October 15, 2015. Mr. Bremer agreed to transfer title to the Company upon payment of $575,000 plus expenses to Mr. Bremer, however, the Company is under no obligation to do so. The mining claims require a minimum royalty payment of $3,500 per year to be made by the Company, which is paid by USMC.

On April 1, 2020, the Company entered into a purchase and sale agreement with the Bremer Family 1995 Living Trust (the “Trust”), pursuant to which the Company will purchase the Snow White Mine for $836,000 (the “Purchase Price”) from the Trust. The Purchase Price plus 5% interest is payable in full in cash at closing. On April 14, 2022, the agreement was amended to extend the closing date to April 14, 2023. On April 7, 2023 the agreement was further amended to extend the Closing Date to April 1, 2024.   

XML

PROPERTY AND EQUIPMENT

6 Months Ended

May 31, 2023

Property, Plant and Equipment [Abstract]

PROPERTY AND EQUIPMENT

NOTE 5 – PROPERTY AND EQUIPMENT

Property and equipment consisted of the following at:

	May 31, 2023			November 30, 2022
Furniture and equipment	$	6,952		$	6,952
Machinery and equipment		35,151			35,151
Automobiles and trucks		25,061			25,061
Construction in process		620,000			620,000
		687,164			687,164
Less: accumulated depreciation		(67,164	)		(67,164	)
Property and equipment, net	$	620,000		$	620,000

There was no depreciation expense for the three or six months ended May 31, 2023 and 2022.

XML

NOTES PAYABLE

6 Months Ended

May 31, 2023

Debt Disclosure [Abstract]

NOTES PAYABLE

NOTE 6 – NOTES PAYABLE

Bayshore Capital Advisors, LLC

On February 26, 2016, the Company issued a promissory note to Bayshore Capital Advisors, LLC (“Bayshore Capital”), an affiliate through common ownership of a 10% major stockholder of the Company, for $25,000 for working capital at an interest rate of 6% per annum. The note was payable August 26, 2016, or when the Company closes a bridge financing, whichever occurs first. On February 4, 2023, Bayshore Capital agreed to cancel the $25,000 debt, plus $10,146 of accrued and unpaid interest. Prior to the cancellation of the note, the Company was in default on the note. Total interest expense on the note was $255 and $750 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on the note was zero and $380 for the three months ended May 31, 2023 and 2022.

A. Scott Dockter – President and Chief Executive Officer

On August 31, 2017, the Company issued a note in the amount of $197,096 to A. Scott Dockter, President, Chief Executive Officer and a director of the Company, to consolidate the total amounts due to Mr. Dockter. The note bears interest at 6% and is due upon demand. During the six months ended May 31, 2023, the Company paid $15,000 towards the outstanding balance of the note. Total interest expense on the note was $612 and $1,706 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on the note was $233 and $837 for the three months ended May 31, 2023 and 2022, respectively. The balance on the note was $13,716 and $28,716 as of May 31, 2023 and November 30, 2022, respectively. There was $41,779 and $41,167 of accrued interest as of May 31, 2023 and November 30, 2022, respectively.

Convertible Promissory Notes – USMC

December 1, 2019

On December 1, 2019, in connection with the September 26, 2019 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $20,000 to USMC, with a maturity date of December 31, 2021 (“Tranche #1”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock, at any time at the option of the holder, at a conversion price of $0.16 per share. On April 7, 2022, the December 1, 2019 note was amended to extend the maturity date to April 30, 2022 and USMC gave notice of conversion of the outstanding principal balance of $20,000 plus accrued interest totaling $2,351 through such date, into 139,692 shares of the Company’s common stock.

The issuance of Tranche #1 resulted in a discount from the beneficial conversion feature totaling $20,000. Total straight-line amortization of this discount was zero for the three and six months ended May 31, 2023 and May 31, 2022. Total interest expense on Tranche #1 was approximately zero and $350 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on Tranche #1 was approximately zero and $100 for the three months ended May 31, 2023 and 2022, respectively.

January 1, 2020

On January 1, 2020, in connection with the September 26, 2019 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $86,000 to USMC, with a maturity date of January 1, 2022 (“Tranche #2”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock, at any time at the option of the holder, at a conversion price of $0.16 per share. On April 7, 2022, the January 1, 2020 note was amended to extend the maturity date to April 30, 2022 and USMC gave notice of conversion of the outstanding principal balance of $86,000 plus accrued interest totaling $9,743 through such date, into 598,392 shares of the Company’s common stock.

The issuance of Tranche #2 resulted in a discount from the beneficial conversion feature totaling $32,250. Total straight-line amortization of this discount totaled zero and $1,412 for the three and six months ended May 31, 2023 and May 31, 2022, respectively. Total interest expense on Tranche #2 was approximately zero and $1,500 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on Tranche #2 was approximately zero and $450 for the three months ended May 31, 2023 and 2022, respectively.

February 1, 2020

On February 1, 2020, in connection with the September 26, 2019 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $72,000 to USMC, with a maturity date of February 1, 2022 (“Tranche #3”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock, at any time at the option of the holder, at a conversion price of $0.16 per share. On April 7, 2022, the February 1, 2020 note was amended to extend the maturity date to April 30, 2022 and USMC gave notice of conversion of the outstanding principal balance of $72,000 plus accrued interest totaling $7,851 through such date, into 499,068 shares of the Company’s common stock.

The issuance of Tranche #3 resulted in a discount from the beneficial conversion feature totaling $36,000. Total straight-line amortization of this discount totaled zero and $3,103 for the six months ended May 31, 2023 and May 31, 2022, respectively. Total interest expense on Tranche #3 was approximately zero and $1,260 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on Tranche #3 was approximately zero and $375 for the three months ended May 31, 2023 and 2022, respectively.

December 1, 2020

On December 1, 2020, in connection with the September 26, 2019 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $822,000 to USMC, with a maturity date of November 25, 2022 (“Tranche 4”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.16 per share. On April 7, 2022 USMC gave notice of conversion of the outstanding principal balance of $822,000 of the December 1, 2020 note, plus accrued interest totaling $55,401 through such date, into 5,483,753 shares of the Company’s common stock. Total interest expense on Tranche #4 was approximately zero and $17,700 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on Tranche #4 was approximately zero and $7,500 for the three months ended May 31, 2023 and 2022, respectively.

March 17, 2021

On March 17, 2021, in connection with the March 11, 2021 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $579,769 to USMC, with a maturity date of March 17, 2023 (“Tranche #5”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.088 per share. On April 7, 2022 USMC gave notice of conversion of the outstanding principal balance of $579,769.39 of the March 17, 2021 note, plus accrued interest totaling $30,656 through such date, into 6,936,656 shares of the Company’s common stock. Total interest expense on Tranche #5 was approximately zero and $8,800 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on Tranche #5 was approximately zero and $1,700 for the three months ended May 31, 2023 and 2022, respectively.

March 14, 2022

On March 14, 2022, in connection with the November 25, 2020 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $884,429 to USMC, with a maturity date of March 14, 2024 (“Tranche #6”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.088 per share. On April 7, 2022 USMC gave notice of conversion of the outstanding principal balance of $884,492 of the March 14, 2022 note, plus accrued interest totaling $2,908 through such date, into 10,084,093 shares of the Company’s common stock. Total interest expense on Tranche #6 was approximately zero and $2,908 for the six months ended May 31, 2023 and May 31, 2022. Total interest expense on Tranche #6 was approximately zero and $2,908 for the three months ended May 31, 2023 and May 31, 2022.

August 30, 2022

On August 30, 2022, in connection with the April 7, 2022 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $470,862 to USMC, with a maturity date of August 30, 2024 (“Tranche #7”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.39 per share. Total interest expense on Tranche #7 was $11,610 for the six months ended May 31, 2023. Total interest expense on Tranche #7 was $5,805 for the three months ended May 31, 2023.

November 29, 2022

On November 29, 2022, in connection with the April 7, 2022 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $140,027 to USMC, with a maturity date of August 30, 2024 (“Tranche #8”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.39 per share. Total interest expense on Tranche #8 was $3,453 for the six months ended May 31, 2023. Total interest expense on Tranche #8 was $1,726 for the three months ended May 31, 2023.

February 28, 2023

On February 28, 2023, in connection with the April 7, 2022 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $308,320 to USMC, with a maturity date of February 28, 2025 (“Tranche #9”). The note bears interest at 5% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.39 per share. Total interest expense on Tranche #9 was $3,801 for the three and six months ended May 31, 2023.

May 31, 2023

On May 31, 2023, in connection with the March 20, 2023 securities purchase agreement with USMC (See Note 12), the Company issued a convertible promissory note in the amount of $412,533 to USMC, with a maturity date of May 31, 2025 (“Tranche #10”). The note bears interest at 8% per annum which is payable on maturity. Amounts due under the note may be converted into shares of the Company’s common stock at any time at the option of the noteholder, at a conversion price of $0.10 per share. There was no interest expense on Tranche #10 for the three and six months ended May 31, 2023.

Line of Credit –USMC

July 10, 2023

On July 10, 2023 , the Company entered into a line of credit agreement and unsecured convertible grid promissory note with USMC. The July 10, 2023 line of credit agreement provides for the issuance for up to one year of up to an aggregate of $1,000,000 of advances from USMC under an unsecured convertible grid promissory note (See Note 12). The note bears interest at 8% annum and any outstanding principal or accrued interest under the note is convertible into shares of the Company’s common stock at a conversion price of $0.10 per share on the maturity date. As of the date hereof, there have been no advances from USMC under the July 10, 2023 line of credit agreement.

Convertible Debt – Board of Directors

On April 8, 2021, the Company entered into a twelve-month director agreement with Jeffrey Guzy, as amended on August 26, 2022 (the “Guzy Director Agreement”) pursuant to which Mr. Guzy will serve as a director of the Company, which agreement will automatically renew (the “Renewal Date”) for successive one-year terms unless either party notifies the other of its desire not to renew the Agreement within 30 days of the expiration of the then current term. As compensation therefor, Mr. Guzy is entitled to a cash fee of $1,000 per month which accrues as 0% debt to the Company until the Company has its first cash-flow positive month. Any amounts owed to Mr. Guzy at the Renewal Date or upon Mr. Guzy’ resignation or removal (the “Termination Date”) will be converted into the Company’s common stock at a price per share equal to the market price on the exchange or trading market where such stock is then traded or quoted or the volume-weighted average price (“VWAP”) of the common stock for the 20days immediately preceding the Renewal Date or the Termination Date, as the case may be. On April 14, 2023, Mr. Guzy converted $24,000 in accrued but unpaid director fees into 80,000 shares of common stock at $0.15 per share and 150,000 shares of common stock at $0.08 per share. As of May 31, 2023, cash fees owed to Mr. Guzy under the Guzy Director Agreement were deferred and debt in the amount of $2,000 is owed to Mr. Guzy.

On August 13, 2021, the Company entered into a twelve-month director agreement with Dr. Kurtis, as amended on August 26, 2022 (the “Kurtis Director Agreement”) pursuant to which Dr. Kurtis will provide up to five hours per month of board services, which agreement will automatically renew for successive one-year terms unless either party notifies the other of its desire not to renew the Agreement within 30 days of the expiration of the then current term. As compensation therefor, Dr. Kurtis is entitled to a cash fee of $1,000 per month which accrues as debt to the Company until the Company has its first cash-flow positive month. Any amounts owed to Dr. Kurtis at the Renewal Date or the Termination Date will be converted into common stock at a price per share equal to market price on the exchange or trading market where such stock is then traded or quoted or the VWAP of the common stock for the 20 days immediately preceding the Renewal Date or the Termination Date, as the case may be. On April 14, 2023, Dr. Kurtis exercised the conversion of $12,000 in accrued but unpaid director fees to purchase 80,000 shares of common stock at $0.15 per share. As of May 31, 2023, cash fees owed to Dr. Kurtis as per the terms of the Kurtis Director Agreement were deferred and debt in the amount of $10,000 is owed to Dr. Kurtis.

XML

LEASES

6 Months Ended

May 31, 2023

Leases

LEASES

NOTE 7 – LEASES

The following table presents net lease cost and other supplemental lease information:

	Six Months Ended May 31, 2023
Lease cost
Operating lease cost (cost resulting from lease payments)	$	21,000
Short term lease cost		-
Sublease income		-
Net lease cost	$	21,000
Operating lease – operating cash flows (fixed payments)	$	21,000
Operating lease – operating cash flows (liability reduction)	$	19,197
Non-current leases – right of use assets	$	59,699
Current liabilities – operating lease liabilities	$	39,869
Non-current liabilities – operating lease liabilities	$	20,696

	Six Months Ended May 31,2022
Lease cost
Operating lease cost (cost resulting from lease payments)	$	9,000
Short term lease cost		-
Sublease income		-
Net lease cost	$	9,000
Operating lease – operating cash flows (fixed payments)	$	9,000
Operating lease – operating cash flows (liability reduction)	$	8,688
Non-current leases – right of use assets	$	7,109
Current liabilities – operating lease liabilities	$	7,407
Non-current liabilities – operating lease liabilities	$	-

Future minimum payments under non-cancelable leases for operating leases for the remaining terms of the leases following the three months ended May 31, 2023:

Fiscal Year	Operating Leases
Remainder of 2023	$	31,500
2024		31,500
Total future minimum lease payments		63,000
Amount representing interest		(2,435	)
Present value of net future minimum lease payments	$	60,565

XML

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

6 Months Ended

May 31, 2023

Payables and Accruals [Abstract]

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

NOTE 8 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consist of the following amounts as of:

	May 31, 2023		November 30, 2022
Accounts payable	$	316,496	$	30,078
Accrued interest – related party		66,595		57,266
Accrued compensation		29,466		28,134
Accounts payable and accrued expenses	$	412,557	$	115,478

XML

COMMITMENTS AND CONTINGENCIES

6 Months Ended

May 31, 2023

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

NOTE 9 – COMMITMENTS AND CONTINGENCIES

Office and Rental Property Leases

The Company is leasing office space from USMC, a company that is owned by the Company’s majority shareholders and directors, A. Scott Dockter and John Bremer (See Note 12).

Mineral Properties

The Company’s mineral rights require various annual lease payments (See Note 4).

Legal Matters

On July 8, 2020, the Company’s former Chief Financial Officer, Al Calvanico (“Calvanico”), filed a demand for arbitration alleging retaliation, wrongful termination, and demand for a minimum of $600,000 in alleged stock value, plus interest, recovery of past and future wages, attorneys’ fees, and punitive damages (collectively, the “Calvanico Claims”). The Company denied all Calvanico Claims. The Company believes Calvanico is owed nothing because it takes the position that Calvanico was not terminated, but rather, his employment contract expired on September 21, 2019, in accordance with its terms, and was not renewed by the Company and because Calvanico never exercised his stock options. On February 14, 2020, the Company requested in writing that Calvanico exercise his stock options within 30 days. Calvanico failed to do so. The Company and Calvanico engaged in binding arbitration which concluded on February 3, 2023. On June 20, 2023, the arbitrator decided in favor of the Company with respect to breach of contract, fraud and negligent representation and wrongful discharge and in favor of Calvanico for attorneys’ fees for Calvanico’s asserted claims in accordance with his employment agreement with the Company. A teleconference was set for July 18, 2023 for determination of the amount of attorneys’ fees to be awarded.

On March 29, 2019, the Company was served with a complaint filed by Superior Soils Supplements LLC (“Superior Soils”) in the Superior Court of the State of California in and for the County of Kings (Case #19C-0124) relating to 64 truckloads of soil amendments delivered to a customer by the Company on behalf of Superior Soils. Superior Soils alleged that the soil amendments were not labeled correctly requiring the entire shipment of product to be returned to the Company. The complaint alleges breach of contract, misrepresentations, fraudulent concealment and unfair competition. The complaint sought damages of approximately $400,000 and, although the Company vigorously defended such claims and believed there was little to no risk of liability, it accrued $400,000 for such risk. On April 28, 2023, the Company and Superior Soils entered into a settlement agreement and mutual release pursuant to which the Company paid $125,000 to Superior Soils and Superior Soils filed a dismissal with prejudice.

Contractual Matters

On November 1, 2013, the Company entered into an agreement with USMC, in which USMC provides various technical evaluations and mine development services for the Company with regard to the various mining properties/rights owned by the Company. Terms of services and compensation will be determined for each project undertaken by USMC.

On October 12, 2018, the Company entered into a material supply agreement with USMC, pursuant to which USMC provides designated natural resources to the Company at predetermined prices (See Note 12).

XML

STOCKHOLDERS’ EQUITY

6 Months Ended

May 31, 2023

Equity [Abstract]

STOCKHOLDERS’ EQUITY

Note 10 - STOCKHOLDERS’ EQUITY

On May 19, 2022, the Company entered into an agreement with Newbridge Securities Corporation (“Newbridge”) for a twelve-month term, pursuant to which Newbridge provided investment banking and corporate advisory services to the Company. As consideration therefor, the Company issued Newbridge 300,000 shares of common stock on June 17, 2022 which shares were subject to a 12-month lockup from the date of issuance. The shares were issued at a fair value of $0.35 per share.

On June 9, 2023, effective April 8, 2023, the Company entered into a one-year advisory agreement with Dr. Karen Scrivener (“Scrivener Agreement”) pursuant to which Dr. Scrivener will provide certain strategic decision advisory  services to the Company. As compensation therefor, Dr. Scrivener was issued 100,000 shares of the Company’s common stock on June 9, 2023 at $0.08 per share.

XML

STOCK-BASED COMPENSATION

6 Months Ended

May 31, 2023

Share-Based Payment Arrangement [Abstract]

STOCK-BASED COMPENSATION

Note 11 – STOCK-BASED COMPENSATION

The Company accounted for its stock-based compensation in accordance with the fair value recognition provisions of FASB ASC Topic 718.

2017 Equity Incentive Plan

On November 10, 2017, the Board approved the 2017 PureBase Corporation Stock Option Plan which is intended to be a qualified stock option plan (the “Option Plan”). The Board reserved 10,000,000 shares of the Company’s common stock to be issued pursuant to options granted under the Option Plan. The Option Plan was subsequently approved by shareholders on September 28, 2018. As of May 31, 2023, options to purchase an aggregate of 128,688,187 shares of common stock have been granted under the Option Plan.

The Company has also granted options to purchase an aggregate of 500,000 shares of common stock pursuant to employment contracts with certain employees prior to the adoption of the Option Plan.

On June 3, 2022, in connection with the settlement agreement with Agregen, Robert Hurtado, James Todd Gauer and John Gingerich, the Company granted James Todd Gauer an immediately exercisable option to purchase 8,669,400 shares of common stock, the equivalent number of shares of common stock that were surrendered to the Company, at an exercise price of $2.50 per share and a fair value of $1,856,151. The option was valued using the Black-Scholes option pricing model under the assumptions in the below table.

On August 26, 2022, the Company granted immediately exercisable options to purchase an aggregate of 2,223,787 shares of common stock to members of the Board, consultants and employees for services to be performed. The options were issued at an exercise price of $0.24 per share and a total fair value of $522,411. The options were valued using the Black-Scholes option pricing model under the assumptions in the below table.

Grant Date	Number of Options		Stock Price		Exercise Price		Expected Volatility			Risk-free Interest Rate			Dividend Rate			Expected Term	Fair Value
4/8/2021		250,000	$	0.15	$	0.10		281.00	%		0.85	%		0.00	%	2.50 years	$	36,708
8/13/2021		200,000	$	0.46	$	0.36		266.00	%		0.79	%		0.00	%	3.50 years	$	90,944
10/6/2021		116,000,000	$	0.38	$	0.38		278.00	%		1.26	%		0.00	%	3.88 years	$	43,808,780
6/3/2022		8,669,400	$	0.22	$	2.50		274.50	%		2.95	%		0.00	%	3.50 years	$	1,856,151
8/26/2022		1,734,615	$	0.24	$	0.24		269.24	%		3.20	%		0.00	%	3.50 years	$	411,668
8/26/2022		242,424	$	0.24	$	0.24		276.76	%		3.20	%		0.00	%	3.00 years	$	57,264
8/26/2022		246,748	$	0.24	$	0.24		207.37	%		3.20	%		0.00	%	2.50 years	$	53,479

The Company did not grant stock options during the six months ended May 31, 2023 and May 31, 2022.

The weighted average non-vested grant date fair value of non-vested options was zero and $10,917,826 at May 31, 2023 and November 30, 2022, respectively.

Compensation based stock option activity for qualified and unqualified stock options are summarized as follows:

			Weighted
	Number of		Average
	Shares		Exercise Price
Outstanding at November 30, 2021		117,795,000	$	0.39
Granted		-		-
Exercised		-		-
Expired or cancelled		-		-
Outstanding at May 31, 2022		117,795,000	$	0.39
Outstanding at November 30, 2022		128,688,187	$	0.53
Granted		-		-
Exercised		-		-
Expired or cancelled		-		-
Outstanding at May 31, 2023		128,688,187	$	0.53

The following table summarizes information about options to purchase shares of the Company’s common stock outstanding and exercisable at May 31, 2023:

				Weighted-		Weighted-
				Average		Average
Exercise		Outstanding		Remaining Life		Exercise		Number
Price		Options		In Years		Price		Exercisable
$	0.10		400,000		1.39	$	0.10		400,000
	0.10		645,000		2.54		0.10		645,000
	0.12		50,000		5.57		0.12		50,000
	0.24		2,223,787		4.16		0.24		2,223,787
	0.36		200,000		3.45		0.36		200,000
	0.38		116,000,000		5.59		0.38		116,000,000
	2.50		8,669,400		4.26		2.50		8,669,400
	3.00		500,000		3.01		3.00		500,000
			128,688,187		5.44	$	0.53		128,688,187

The compensation expense attributed to the issuance of the options is recognized as options vest.

The stock options granted are exercisable over various terms from thee to ten years from the grant date and vest over various terms from the grant date to five years.

Total compensation expense related to the options was $7,326,402 and $18,254,083 for the six months ended May 31, 2023 and May 31, 2022, respectively. Total compensation expense related to the options was $1,841,389 and $7,304,345 for the three months ended May 31, 2023 and May 31, 2022, respectively. As of May 31, 2023, there was no future compensation cost related to non-vested stock options.

The aggregate intrinsic value is $31,155 for total outstanding and exercisable options, which was based on an estimated fair value of the Company’s common stock of $0.13 as of May 31, 2023, which is the aggregate fair value of the common stock that would have been received by the option holders had all option holders exercised their options as of that date, net of the aggregate exercise price.

XML

RELATED PARTY TRANSACTIONS

6 Months Ended

May 31, 2023

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

NOTE 12 – RELATED PARTY TRANSACTIONS

Bayshore Capital Advisors, LLC

On February 26, 2016, the Company issued a promissory note to Bayshore Capital Advisors, LLC (“Bayshore Capital”), an affiliate through common ownership of a 10% major stockholder of the Company, for $25,000 for working capital at an interest rate of 6% per annum. The note was payable August 26, 2016, or when the Company closes a bridge financing, whichever occurs first. On February 4, 2023, Bayshore Capital agreed to cancel the $25,000 debt, plus $10,146 of accrued and unpaid interest. Prior to the cancellation of the note, the Company was in default on the note. Total interest expense on the note was $255 and $750 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on the note was zero and $380 for the three months ended May 31, 2023 and 2022, respectively.

US Mine Corporation

The Company entered into a contract mining agreement with USMC, a company which A. Scott Dockter, the Company’s Chief Executive Officer and a director, and John Bremer, a director, each own 33%, pursuant to which USMC provides various technical evaluations and mine development services to the Company. During the six months ended May 31, 2023 and 2022, the Company made $34,364 and no purchases from USMC, respectively. No services were rendered by USMC for the six months ended May 31, 2023 and 2022. In addition, during the six months ended May 31, 2023 and 2022, USMC paid $15,853 and $4,438, respectively, of expenses to the Company’s vendors and creditors on behalf of the Company. During the six months ended May 31, 2023 and 2022, USMC made cash advances to the Company of $705,000 and $410,000, respectively, which are recorded as part of due to affiliates and convertible notes payable, related party on the Company’s condensed consolidated balance sheets. All amounts owed for services rendered, expenses paid on behalf of the Company, and cash advances were converted into the Company’s common stock pursuant to the September 5, 2019 Debt Exchange Agreement, the November 25, 2020 Securities Purchase Agreement (See Note 6) and the April 7, 2022 Securities Purchase Agreement (See Note 6). The Company had a balance due of $406,604 and zero to USMC on May 31, 2023 and November 30, 2022, respectively.

USMC Notes

The Company has entered into various securities purchase agreements with USMC pursuant to which USMC may purchase the Company’s unsecured convertible promissory notes (See Note 6). The outstanding balance on the convertible notes due to USMC was $1,331,742 and $610,889 on May 31, 2023 and November 30, 2022, respectively. Interest expense on the convertible notes due to USMC totaled $18,864 and $32,518 for the six months ended May 31, 2023 and May 31, 2022, respectively. Interest expense on the convertible notes due to USMC totaled $11,333 and $13,033 for the three months ended May 31, 2023 and May 31, 2022, respectively.

USMC Line of Credit

On July 10, 2023, the Company entered into a line of credit agreement and unsecured convertible grid promissory note with USMC. The July 10, 2023 line of credit agreement provides for the issuance for up to one year of up to an aggregate of $1,000,000 of advances from USMC under an unsecured convertible grid promissory note (See Note 6). The note bears interest at 8% annum and any outstanding principal or accrued interest under the note is convertible into shares of the Company’s common stock at a conversion price of $0.10 per share on the maturity date. As of the date hereof, there have been no advances from USMC under the July 10, 2023 line of credit agreement.

USMC Mining Agreements

On April 22, 2020, the Company entered into a Material Supply Agreement (the “Supply Agreement”) with USMC which amended the prior Materials Supply Agreement entered into on October 12, 2018. Under the terms of the Supply Agreement, all kaolin clay purchased by the Company from USMC under the Supply Agreement must be used exclusively for agricultural products and supplementary cementitious materials. The Company will pay $25 per ton for the kaolin clay for supplementary cementitious materials and $145 per ton for bagged products for clay for agriculture (in each case plus an additional $5 royalty fee per ton). The Supply Agreement also provides that if USMC provides pricing to any other customer which is more favorable than that provided to the Company, USMC will adjust the cost to the Company to conform to the more favorable terms. The initial term of the Supply Agreement is three years, which automatically renews for three successive one-year terms, unless either party provides notice of termination at least sixty days prior to the end of the then current term. Either party has the right to terminate the Supply Agreement for a material breach which is not cured within 90 days. For the six months ended May 31, 2023 and 2022, the Company purchased $34,365 and $72,236, respectively, under the Supply Agreement. For the three months ended May 31, 2023 and 2022, the Company purchased $12,450 and $72,236, respectively, under the Supply Agreement. Since April 22, 2020, the Company has purchased $292,806 of materials under the Supply Agreement.

US Mine LLC

On May 27, 2021, the Company entered into the Materials Extraction Agreement with US Mine, LLC, pursuant to which the Company acquired the right to extract up to 100,000,000 of certain raw clay materials. The Materials Extraction Agreement is effective until 100,000,000 tons of material are extracted. As compensation for such right, the Company issued a ten-year convertible promissory note in the principal amount of $50,000,000 to US Mine, LLC (the “US Mine Note”). The US Mine Note bears interest at the rate of 2.5% per annum which is payable upon maturity. Amounts due under the US Mine Note may be converted into shares of the Company’s common stock at the option of the noteholder, at a conversion price of $0.43 per share. The noteholder may convert (i) up to 50% of the outstanding balance on or after such date as the Company’s common stock is listed for trading on any national securities exchange, (ii) up to an additional 25% of the outstanding balance on or after the six-month anniversary of such initial trading date, and (iii) the remaining 25% on or after the twelve-month anniversary of such initial trading date. In addition, the Company will pay US Mine, LLC a royalty fee of $5.00 per ton of materials extracted and any royalty not paid in a timely manner with be subject to 15% interest per annum and compounded monthly.

On October 6, 2021, and prior to consummation of activities under the Materials Extraction Agreement, the Company and US Mine, LLC executed an amendment to the Materials Extraction Agreement (the “Amendment”). Pursuant to the Amendment, the US Mine Note was retroactively rescinded, ab initio and an option to purchase an aggregate of 116,000,000 shares of the Company’s common stock at an exercise price of $0.38 per share until April 6, 2028, was issued to US Mine, LLC as compensation. Shares subject to the option vested as to 58,000,000 shares on April 6, 2022, 29,000,000 shares on October 6, 2022, and 29,000,000 shares on April 6, 2023. This agreement was further amended and restated on June 21, 2022, with the same option purchase, vesting and exercise schedule. For the three and six months ended May 31, 2023 the Company expensed $1,841,389 and $7,326,402 in stock-based compensation expense related to the issuance of the option on October 16, 2021 to US Mine LLC under the Materials Extraction Agreement.

Transactions with Officers

On August 31, 2017, the Company issued a note in the amount of $197,096 to A. Scott Dockter, President, Chief Executive Officer and a director of the Company, to consolidate the total amounts due to Mr. Dockter. The note bears interest at 6% and is due upon demand. During the six months ended May 31, 2023, the Company paid $15,000 towards the outstanding balance of the note. Total interest expense on the note was $612 and $1,706 for the six months ended May 31, 2023 and 2022, respectively. Total interest expense on the note was $233 and $837 for the three months ended May 31, 2023 and 2022, respectively. The balance on the note was $13,716 and $28,716 as of May 31, 2023 and November 30, 2022, respectively. There was $41,779 and $41,167 of accrued interest as of May 31, 2023 and November 30, 2022, respectively.

Convertible Debt – Board of Directors

On April 8, 2021, the Company entered into the Guzy Director Agreement (See Note 6) pursuant to which Mr. Guzy will serve as a director of the Company, which agreement will automatically renew for successive one-year terms unless either party notifies the other of its desire not to renew the Agreement within 30 days of the expiration of the then current term. As compensation therefor, Mr. Guzy is entitled to a cash fee of $1,000 per month which accrues as 0% debt to the Company until the Company has its first cash-flow positive month. Any amounts owed to Mr. Guzy at the Renewal Date or upon Mr. Guzy’ resignation or removal will be converted into common stock at a price per share equal to market price on the exchange or trading market where such stock is then traded or quoted or the VWAP of the common stock for the 20-days immediately preceding the Renewal Date or the Termination Date, as the case may be. The Agreement also includes a non-competition provision during the term of the Agreement and for twelve months thereafter.

On August 13, 2021, the Company entered into the Kurtis Director Agreement (See Note 6) pursuant to which Dr. Kurtis will provide up to five hours per month of board services, which agreement will automatically renew for successive one-year terms unless either party notifies the other of its desire not to renew the Agreement within 30 days of the expiration of the then current term. As compensation therefor, Dr. Kurtis is entitled to a cash fee of $1,000 per month which accrues as debt to the Company until the Company has its first cash-flow positive month. Any amounts owed to Dr. Kurtis at the Renewal Date or upon Dr. Kurtis’ resignation or removal will be converted into common stock at a price per share equal to market price on the exchange or trading market where such stock is then traded or quoted or the VWAP of the common stock for the 20-days immediately preceding the Renewal Date or the Termination Date, as the case may be. The Agreement includes a non-competition provision during the term of the Agreement and for twelve months thereafter.

On June 9, 2023, effective April 8, 2023, the Company entered into a one-year advisory agreement with Dr. Karen Scrivener (“Scrivener Agreement”) pursuant to which Dr. Scrivener will provide certain advisory services to the Company. As compensation therefor, Dr. Scrivener was issued 100,000 shares of the Company’s common stock on June 9, 2023 at $0.08 per share.

Leases

On October 1, 2020, the Company entered into a two-year lease agreement for its office space with USMC with a monthly rent of $1,500 (See Note 7). The lease was amended to extend the term for an additional two years to November 1, 2024 and to add an additional 700 square feet of office space for a total monthly rental price of $3,500 per month,

XML

CONCENTRATION OF CREDIT RISK

6 Months Ended

May 31, 2023

Risks and Uncertainties [Abstract]

CONCENTRATION OF CREDIT RISK

NOTE 13 – CONCENTRATION OF CREDIT RISK

Cash Deposits

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of May 31, 2023 and November 30, 2022, the Company had no deposits in excess of the FDIC insured limit.

Revenues

Three customers accounted for 99% of total revenue for the six months ended May 31, 2023, as set forth below:

Customer A	44	%
Customer B	40	%
Customer C	15	%

Three customers accounted for 100% of total revenue for the six months ended May 31, 2022, as set forth below:

Customer A	84	%
Customer B	8	%
Customer C	8	%

Accounts Receivable

Two customers accounted for 100% of the accounts receivable as of May 31, 2023, as set forth below:

Customer A	73	%
Customer B	27	%

There were no receivables as of November 30, 2022.

Vendors

One supplier accounted for 100% of purchases for the three months ended May 31, 2023.

Three suppliers accounted for 60% of purchases as of May 31, 2022, as set forth below:

Vendor A	31	%
Vendor B	16	%
Vendor C	13	%

XML

SUBSEQUENT EVENTS

6 Months Ended

May 31, 2023

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 14 – SUBSEQUENT EVENTS

In accordance with ASC 855, Subsequent Events, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events and transactions that occurred after May 31, 2023 through the date the condensed consolidated financial statements were filed. During this period the Company did not have any material reportable subsequent events other than those stated below:

On July 10, 2023, the Company entered into a line of credit agreement and unsecured convertible grid promissory note with USMC. The July 10, 2023 line of credit agreement provides for the issuance for up to one year of up to an aggregate of $1,000,000 of advances from USMC under an unsecured convertible grid promissory note (See Note 12). The note bears interest at 8% annum and any outstanding principal or accrued interest under the note is convertible into shares of the Company’s common stock at a conversion price of $0.10 per share on the maturity date. As of the date hereof, there have been no advances from USMC under the July 10, 2023 line of credit agreement.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

6 Months Ended

May 31, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) including Form 10-Q and Regulation S-X. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments, unless otherwise indicated) which are, in the opinion of management, necessary to fairly state the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been omitted pursuant to such rules and regulations. These financial statements and the information included under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read in conjunction with the audited financial statements and notes thereto for the year ended November 30, 2022 in our Annual Report on Form 10-K filed on February 28, 2023 with the SEC. The results of the six months ended May 31, 2023 (unaudited) are not necessarily indicative of the results to be expected for the full year ending November 30, 2023.

Principles of Consolidation

Principles of Consolidation

These condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries PureBase AG and PureBase SCM. Intercompany accounts and transactions have been eliminated upon consolidation.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and equity-based transactions at the date of the financial statements and the revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the condensed consolidated financial statements. Significant estimates include the useful lives of property and equipment, deferred tax asset and valuation allowance, and assumptions used in the Black-Scholes valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.

Revenue

Revenue

The Company accounts for revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers. The Company derives revenues from the sale of products from its agricultural sector and construction sector. The Company’s contracted transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The Company’s contracts have a single performance obligation which are not separately identifiable from other promises in the contracts and is, therefore, not distinct. The Company’s performance obligation is satisfied upon the transfer of risk of loss to the customer.

Practical Expedients

As part of ASC Topic 606, the Company has adopted several practical expedients including:

● Significant Financing Component – the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to the customer and when the customer pays for that good or service will be one year or less.

● Unsatisfied and Partially Unsatisfied Performance Obligations – for all performance obligations related to contracts with a duration for less than one year, the Company has elected to apply the optional exemption provided in ASC Topic 606 and therefore is not required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially satisfied at the end of the reporting period.

● Shipping and Handling Activities – the Company elected to account for shipping and handling activities as a fulfillment cost rather than as a separate performance obligation.

● Right to Invoice – the Company has a right to consideration from a customer in an amount that corresponds directly with the value provided to the customer of the Company’s performance completed to date. The Company may recognize revenue in the amount to which the entity has a right to invoice.

Disaggregated Revenue

Revenue consists of the following by product offering for the six months ended May 31, 2023:

CROP WHITE II		SHADE ADVANTAGE (WP)		SulFe Hume Si ADVANTAGE		Total
$	-	$	67,152	$	51,480	$	118,632

Revenue consists of the following by product offering for the six months ended May 31, 2022:

CROP WHITE II		SHADE ADVANTAGE (WP)		SulFe Hume Si ADVANTAGE		Total
$	192,780	$	35,696	$	-	$	228,476

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. There were no cash equivalents as of May 31, 2023 and November 30, 2022.

Accounts Receivable

Accounts Receivable

The Company periodically assesses its accounts and other receivables for collectability on a specific identification basis. If collectability of an account becomes unlikely, an allowance is recorded for that doubtful account. As of May 31, 2023 and November 30, 2022, the Company has determined that no allowance for doubtful accounts was necessary.

Property and Equipment

Property and Equipment

 Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, generally three to five years. Expenditures that enhance the useful lives of the assets are capitalized and depreciated.

Equipment	3-5 years
Autos and trucks	5 years

Maintenance and repairs are charged to expense as incurred. At the time of retirement or other disposition of property and equipment, the cost and accumulated depreciation will be removed from the accounts and the resulting gain or loss, if any, will be reflected in operations. The Company currently has $620,000 in property and equipment, primarily two ball mills, acquired on May 1, 2020. As of May 31, 2023, the Company has not put the acquired property and equipment to use. As such, the Company has not recorded depreciation related to these assets.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of these assets is determined by comparing the forecasted undiscounted net cash flows of the operation to which the assets relate to the carrying amount. If the operation is determined to be unable to recover the carrying amount of its assets, then these assets are written down first, followed by other long-lived assets of the operation to fair value. Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets. No impairment losses were recorded during the three and six months ended May 31, 2023 and May 31, 2022.

Shipping and Handling

Shipping and Handling

The Company incurs shipping and handling costs which are charged back to the customer. The Company did not incur shipping and handling costs during the three months ended May 31, 2023 and 2022, respectively. The Company incurred shipping and handling costs of $2,000 and no shipping and handling costs during the six months ended May 31, 2023 and 2022, respectively.

Advertising and Marketing Costs

Advertising and Marketing Costs

The Company expenses advertising and marketing costs as incurred and such costs are recorded in selling, general and administrative expenses in the accompanying condensed consolidated statements of operations. Advertising and marketing expenses were $2,643 for the three and six months ended May 31, 2023. There were no advertising and marketing expenses for the three and six months ended May 31, 2022.

Fair Value Measurements

Fair Value Measurements

As defined in ASC 820, Fair Value Measurements and Disclosures, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.

Level 1:	Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
Level 2:	Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.
Level 3:	Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The carrying value of cash, accounts receivable, accounts payable, and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amount of notes approximates the estimated fair value for these financial instruments as management believes that such notes constitute substantially all of the Company’s debt and interest payable on the notes based on the Company’s incremental borrowing rate.

Loss Per Common Share

Loss Per Common Share

Net loss per share of common stock is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the three and six month periods ended May 31, 2023 and 2022. All outstanding options are considered potential common stock. The dilutive effect, if any, of stock options are calculated using the treasury stock method. All outstanding convertible notes are considered common stock at the beginning of the period or at the time of issuance, if later, pursuant to the if-converted method. Since the effect of common stock equivalents is anti-dilutive with respect to losses, outstanding options have been excluded from the Company’s computation of net loss per share of common stock for the three and six months ended May 31, 2023 and May 31, 2022.

The following table summarizes the stocks that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive due to the Company’s net loss position even though the exercise price could be less than the average market price of the common stock:

	Three Months Ended,
	May 31, 2023		May 31, 2022
Convertible Notes		6,656,110		-
Stock Options		128,688,187		1,595,000
Total		135,344,297		1,595,000

	Six Months Ended,
	May 31, 2023		May 31, 2022
Convertible Notes		6,656,110		-
Stock Options		128,688,187		59,595,000
Total		135,344,297		59,595,000

Stock-Based Compensation

Stock-Based Compensation

The Company applies the provisions of ASC 718, Compensation—Stock Compensation (“ASC 718”), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees, including employee stock options, in the accompanying condensed consolidated statements of operations.

For stock options issued to employees and members of the Company’s Board of Directors (the “Board”) for their services, the Company estimates the grant date fair value of each option using the Black-Scholes option pricing model. The use of the Black-Scholes option pricing model requires management to make assumptions with respect to the expected term of the option, the expected volatility of the common stock consistent with the expected life of the option, risk-free interest rates and expected dividend yields of the common stock. For awards subject to service-based vesting conditions, including those with a graded vesting schedule, the Company recognizes stock-based compensation expense equal to the grant date fair value of stock options on a straight-line basis over the requisite service period, which is generally the vesting term. Forfeitures are recorded as they are incurred as opposed to being estimated at the time of grant and revised.

Pursuant to ASU 2018-07 Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, the Company accounts for stock options issued to non-employees for their services in accordance with ASC 718. The Company uses valuation methods and assumptions to value the stock options that are in line with the process for valuing employee stock options as noted above.

Leases

Leases

With the adoption of ASC 842, Leases, operating lease agreements are required to be recognized on the balance sheet as Right-of-Use (“ROU”) assets and corresponding lease liabilities. ROU assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The lease terms may include options to extend or terminate the lease if it is reasonably certain that the Company will exercise that option.

The Company leases its corporate offices. All of the leases are classified as operating leases. The Company is a party to a two-year lease with USMC for 1,000 square feet of office space located in Ione, California (the “Ione Lease”) with respect to its corporate operations (See Note 7). Effective November 1, 2022, the Ione Lease was amended to extend the lease through October 2024 and to add an additional 700 square feet of office space for a total monthly rental price of $3,500 per month, with automatic one-month renewals. The remaining weighted average term is 1.4 years. The Company discounted lease payments using its estimated incremental borrowing rate at December 1, 2020. The weighted average incremental borrowing rate applied was 5%.

In accordance with ASC 842, the Company recognized a ROU asset and corresponding lease liability on the condensed consolidated balance sheet for long-term office leases. See Note 7 – Leases for further discussion, including the impact on the accompanying unaudited condensed consolidated financial statements and related disclosures.

Income Taxes

Income Taxes

Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the condensed consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.

The Company utilizes ASC 740, Income Taxes, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the condensed consolidated financial statements or tax returns. The Company accounts for income taxes using the asset and liability method to compute the differences between the tax basis of assets and liabilities and the related financial amounts, using currently enacted tax rates. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

For uncertain tax positions that meet a “more likely than not” threshold, the Company recognizes the benefit of uncertain tax positions in the condensed consolidated financial statements. The Company’s practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in the condensed consolidated statements of operations.

Exploration Stage

Exploration Stage

In accordance with U.S. GAAP, expenditures relating to the acquisition of mineral rights are initially capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time as the Company exits the exploration stage by establishing proven or probable reserves. Expenditures relating to exploration activities such as drill programs to establish mineralized materials are expensed as incurred. Expenditures relating to pre-extraction activities are expensed as incurred until such time proven or probable reserves are established for that project, after which expenditures relating to mine development activities for that particular project are capitalized as incurred. As of May 31, 2023, the Company was not engaged in any mine exploration.

Mineral Rights

Mineral Rights

Acquisition costs of mineral rights are capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time as the Company exits the exploration stage by establishing proven or probable reserves, as defined by the SEC under Industry Guide 7, through the completion of a “final” or “bankable” feasibility study. Expenditures relating to exploration activities are expensed as incurred and expenditures relating to pre-extraction activities are expensed as incurred until such time proven or probable reserves are established for that project, after which subsequent expenditures relating to development activities for that particular project are capitalized as incurred.

Where proven and probable reserves have been established, the project’s capitalized expenditures are depleted over proven and probable reserves upon commencement of production using the units-of-production method. Where proven and probable reserves have not been established, such capitalized expenditures are depleted over the estimated production life upon commencement of extraction using the straight-line method.

The carrying values of the mineral rights are assessed for impairment by management on a quarterly basis or when indicators of impairment exist. Should management determine that these carrying values cannot be recovered, the unrecoverable amounts are written off against earnings. As of May 31, 2023 and 2022, the Company did not have any capitalized mineral rights.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

All newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

May 31, 2023

Accounting Policies [Abstract]

SCHEDULE OF DISAGGREGATED REVENUE

Revenue consists of the following by product offering for the six months ended May 31, 2023:

CROP WHITE II		SHADE ADVANTAGE (WP)		SulFe Hume Si ADVANTAGE		Total
$	-	$	67,152	$	51,480	$	118,632

Revenue consists of the following by product offering for the six months ended May 31, 2022:

CROP WHITE II		SHADE ADVANTAGE (WP)		SulFe Hume Si ADVANTAGE		Total
$	192,780	$	35,696	$	-	$	228,476

SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT

Equipment	3-5 years
Autos and trucks	5 years

SCHEDULE OF OUTSTANDING SHARES EXCLUDED FROM DILUTED LOSS PER SHARE

The following table summarizes the stocks that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive due to the Company’s net loss position even though the exercise price could be less than the average market price of the common stock:

	Three Months Ended,
	May 31, 2023		May 31, 2022
Convertible Notes		6,656,110		-
Stock Options		128,688,187		1,595,000
Total		135,344,297		1,595,000

	Six Months Ended,
	May 31, 2023		May 31, 2022
Convertible Notes		6,656,110		-
Stock Options		128,688,187		59,595,000
Total		135,344,297		59,595,000

XML

PROPERTY AND EQUIPMENT (Tables)

6 Months Ended

May 31, 2023

Property, Plant and Equipment [Abstract]

SCHEDULE OF PROPERTY AND EQUIPMENT

Property and equipment consisted of the following at:

	May 31, 2023			November 30, 2022
Furniture and equipment	$	6,952		$	6,952
Machinery and equipment		35,151			35,151
Automobiles and trucks		25,061			25,061
Construction in process		620,000			620,000
		687,164			687,164
Less: accumulated depreciation		(67,164	)		(67,164	)
Property and equipment, net	$	620,000		$	620,000

XML

LEASES (Tables)

6 Months Ended

May 31, 2023

Leases

SCHEDULE OF LEASE COST AND OTHER SUPPLEMENTAL LEASE INFORMATION

The following table presents net lease cost and other supplemental lease information:

	Six Months Ended May 31, 2023
Lease cost
Operating lease cost (cost resulting from lease payments)	$	21,000
Short term lease cost		-
Sublease income		-
Net lease cost	$	21,000
Operating lease – operating cash flows (fixed payments)	$	21,000
Operating lease – operating cash flows (liability reduction)	$	19,197
Non-current leases – right of use assets	$	59,699
Current liabilities – operating lease liabilities	$	39,869
Non-current liabilities – operating lease liabilities	$	20,696

	Six Months Ended May 31,2022
Lease cost
Operating lease cost (cost resulting from lease payments)	$	9,000
Short term lease cost		-
Sublease income		-
Net lease cost	$	9,000
Operating lease – operating cash flows (fixed payments)	$	9,000
Operating lease – operating cash flows (liability reduction)	$	8,688
Non-current leases – right of use assets	$	7,109
Current liabilities – operating lease liabilities	$	7,407
Non-current liabilities – operating lease liabilities	$	-

SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS

Future minimum payments under non-cancelable leases for operating leases for the remaining terms of the leases following the three months ended May 31, 2023:

Fiscal Year	Operating Leases
Remainder of 2023	$	31,500
2024		31,500
Total future minimum lease payments		63,000
Amount representing interest		(2,435	)
Present value of net future minimum lease payments	$	60,565

XML

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)

6 Months Ended

May 31, 2023

Payables and Accruals [Abstract]

SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consist of the following amounts as of:

	May 31, 2023		November 30, 2022
Accounts payable	$	316,496	$	30,078
Accrued interest – related party		66,595		57,266
Accrued compensation		29,466		28,134
Accounts payable and accrued expenses	$	412,557	$	115,478

XML

STOCK-BASED COMPENSATION (Tables)

6 Months Ended

May 31, 2023

Share-Based Payment Arrangement [Abstract]

SCHEDULE OF BLACK-SCHOLES OPTION MODEL ASSUMPTIONS

Grant Date	Number of Options		Stock Price		Exercise Price		Expected Volatility			Risk-free Interest Rate			Dividend Rate			Expected Term	Fair Value
4/8/2021		250,000	$	0.15	$	0.10		281.00	%		0.85	%		0.00	%	2.50 years	$	36,708
8/13/2021		200,000	$	0.46	$	0.36		266.00	%		0.79	%		0.00	%	3.50 years	$	90,944
10/6/2021		116,000,000	$	0.38	$	0.38		278.00	%		1.26	%		0.00	%	3.88 years	$	43,808,780
6/3/2022		8,669,400	$	0.22	$	2.50		274.50	%		2.95	%		0.00	%	3.50 years	$	1,856,151
8/26/2022		1,734,615	$	0.24	$	0.24		269.24	%		3.20	%		0.00	%	3.50 years	$	411,668
8/26/2022		242,424	$	0.24	$	0.24		276.76	%		3.20	%		0.00	%	3.00 years	$	57,264
8/26/2022		246,748	$	0.24	$	0.24		207.37	%		3.20	%		0.00	%	2.50 years	$	53,479

SCHEDULE OF STOCK OPTION ACTIVITY

Compensation based stock option activity for qualified and unqualified stock options are summarized as follows:

			Weighted
	Number of		Average
	Shares		Exercise Price
Outstanding at November 30, 2021		117,795,000	$	0.39
Granted		-		-
Exercised		-		-
Expired or cancelled		-		-
Outstanding at May 31, 2022		117,795,000	$	0.39
Outstanding at November 30, 2022		128,688,187	$	0.53
Granted		-		-
Exercised		-		-
Expired or cancelled		-		-
Outstanding at May 31, 2023		128,688,187	$	0.53

SCHEDULE OF STOCK OPTION SHARES OUTSTANDING AND EXERCISABLE

The following table summarizes information about options to purchase shares of the Company’s common stock outstanding and exercisable at May 31, 2023:

				Weighted-		Weighted-
				Average		Average
Exercise		Outstanding		Remaining Life		Exercise		Number
Price		Options		In Years		Price		Exercisable
$	0.10		400,000		1.39	$	0.10		400,000
	0.10		645,000		2.54		0.10		645,000
	0.12		50,000		5.57		0.12		50,000
	0.24		2,223,787		4.16		0.24		2,223,787
	0.36		200,000		3.45		0.36		200,000
	0.38		116,000,000		5.59		0.38		116,000,000
	2.50		8,669,400		4.26		2.50		8,669,400
	3.00		500,000		3.01		3.00		500,000
			128,688,187		5.44	$	0.53		128,688,187

XML

CONCENTRATION OF CREDIT RISK (Tables)

6 Months Ended

May 31, 2023

Risks and Uncertainties [Abstract]

SCHEDULE OF CONCENTRATION OF CREDIT RISK

Three customers accounted for 99% of total revenue for the six months ended May 31, 2023, as set forth below:

Customer A	44	%
Customer B	40	%
Customer C	15	%

Three customers accounted for 100% of total revenue for the six months ended May 31, 2022, as set forth below:

Customer A	84	%
Customer B	8	%
Customer C	8	%

Accounts Receivable

Two customers accounted for 100% of the accounts receivable as of May 31, 2023, as set forth below:

Customer A	73	%
Customer B	27	%

Three suppliers accounted for 60% of purchases as of May 31, 2022, as set forth below:

Vendor A	31	%
Vendor B	16	%
Vendor C	13	%

 

XML

ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)	6 Months Ended
	May 31, 2023
Accounting Policies [Abstract]
Entity incorporation, state or country code	NV
Entity incorporation, date of incorporation	Mar. 02, 2010

XML

GOING CONCERN AND LIQUIDITY (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022	Jul. 10, 2023	Mar. 07, 2023	Nov. 30, 2022	Mar. 23, 2022
Defined Benefit Plan Disclosure [Line Items]
Accumulated deficit	$ 61,493,664		$ 61,493,664				$ 53,643,649
Working capital deficit	387,334		387,334
Loss from operations	2,281,815	$ 7,482,364	8,138,892	$ 18,686,017
Cash used in operating activities			685,807	$ 425,780
Debt instrument face amount						$ 412,533
US Mine Corporation [Member]
Defined Benefit Plan Disclosure [Line Items]
Debt instrument face amount	919,209		919,209			$ 1,000,000		$ 1,000,000
Debt instrument interest rate stated percentage						8.00%		5.00%
Debt instrument convertible conversion price						$ 0.10		$ 0.39
US Mine Corporation [Member] | Subsequent Event [Member]
Defined Benefit Plan Disclosure [Line Items]
Debt instrument face amount					$ 1,000,000
Debt instrument interest rate stated percentage					8.00%
Debt instrument convertible conversion price					$ 0.10
US Mine Corporation [Member] | Convertible Notes Payable [Member]
Defined Benefit Plan Disclosure [Line Items]
Debt instrument face amount	$ 80,791		$ 80,791			$ 587,467

XML

SCHEDULE OF DISAGGREGATED REVENUE (Details) - USD ($)	3 Months Ended		6 Months Ended
	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022
Product Information [Line Items]
Revenue, net	$ 66,376	$ 228,476	$ 118,632	$ 228,476
CROP WHITE II [Member]
Product Information [Line Items]
Revenue, net				192,780
Shade Advantage (WP) [Member]
Product Information [Line Items]
Revenue, net			67,152	35,696
SulFe Hume Si ADVANTAGE [Member]
Product Information [Line Items]
Revenue, net			$ 51,480

XML

SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT (Details)	May 31, 2023
Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years
Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years
Autos and Trucks [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years

XML

SCHEDULE OF OUTSTANDING SHARES EXCLUDED FROM DILUTED LOSS PER SHARE (Details) - shares	3 Months Ended		6 Months Ended
	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities	135,344,297	1,595,000	135,344,297	59,595,000
Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities	6,656,110		6,656,110
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities	128,688,187	1,595,000	128,688,187	59,595,000

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	3 Months Ended		6 Months Ended
	May 31, 2023 USD ($) ft²	May 31, 2022 USD ($)	May 31, 2023 USD ($) ft²	May 31, 2022 USD ($)	Nov. 30, 2022 USD ($)
Property, Plant and Equipment [Line Items]
Cash equivalents	$ 0		$ 0		$ 0
Allowance for doubtful accounts receivable	0		0		0
Property and equipment, net	620,000		620,000		$ 620,000
Impairment losses	0	$ 0	0	$ 0
Selling, general and administrative	2,321,585	7,622,810	8,208,455	18,823,211
Advertising and marketing expenses	$ 2,643	$ 0	$ 2,643	0
Area of land | ft²	700		700
Payments for rent			$ 3,500
Weighted average term	1 year 4 months 24 days		1 year 4 months 24 days
Weighted average borrowing rate	5.00%		5.00%
US Mine Corporation [Member]
Property, Plant and Equipment [Line Items]
Area of land | ft²	1,000		1,000
Shipping and Handling [Member]
Property, Plant and Equipment [Line Items]
Selling, general and administrative			$ 2,000	$ 0
Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	3 years		3 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years		5 years

XML

MINING RIGHTS (Details Narrative)	Apr. 01, 2020 USD ($)	Oct. 15, 2015 USD ($)	Dec. 01, 2014 USD ($) a Placer	Nov. 28, 2014 USD ($)	May 31, 2023 ft²
Reserve Quantities [Line Items]
Acres of land | ft²					700
Purchase and Sale Agreement [Member] | Snow White Pozzolan Mine [Member]
Reserve Quantities [Line Items]
Purchase mining properties	$ 836,000
Interest rate	5.00%
Snow White Mine [Member] | California, San Bernardino [Member] | Purchase Agreement [Member] | US Mining and Minerals Corp [Member]
Reserve Quantities [Line Items]
Acres of land | a			280
Number of placer mining claim | Placer			5
Escrow deposit			$ 50,000	$ 600,000
Payment for extend to close purchase agreement			$ 25,000
Snow White Mine [Member] | California, San Bernardino [Member] | Purchase Agreement [Member] | US Mining and Minerals Corp [Member] | Mr. John Bremer [Member]
Reserve Quantities [Line Items]
Payment for purchased property		$ 575,000
Royalty payment		$ 3,500

XML

SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)	May 31, 2023	Nov. 30, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 687,164	$ 687,164
Less: accumulated depreciation	(67,164)	(67,164)
Property and equipment, net	620,000	620,000
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,952	6,952
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	35,151	35,151
Automobiles and Trucks [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	25,061	25,061
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 620,000	$ 620,000

XML

PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 0	$ 0	$ 0	$ 0

XML

NOTES PAYABLE (Details Narrative) - USD ($)																3 Months Ended		6 Months Ended
	May 31, 2023	Apr. 14, 2023	Feb. 28, 2023	Nov. 29, 2022	Aug. 30, 2022	Apr. 07, 2022	Mar. 14, 2022	Aug. 13, 2021	Apr. 08, 2021	Mar. 17, 2021	Dec. 02, 2020	Feb. 01, 2020	Jan. 01, 2020	Dec. 01, 2019	Feb. 26, 2016	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022	Jul. 10, 2023	Mar. 07, 2023	Feb. 04, 2023	Nov. 30, 2022	Aug. 31, 2017
Short-Term Debt [Line Items]
Debt issued amount																					$ 412,533
Repayments notes payable																		$ 15,000	$ 10,000
Amortization of debt discount																			5,329
Officers compensation																		12,000
Convertible notes payable	$ 12,000															$ 12,000		12,000					$ 36,000
Director Agreement [Member] | Jeffrey Guzy [Member]
Short-Term Debt [Line Items]
Interest debt									0.00%
Conversion of stock amount		$ 24,000
Officers compensation									$ 1,000
Convertible notes payable	2,000															2,000		2,000
Director Agreement [Member] | Jeffrey Guzy [Member] | Share Price 0.15 [Member]
Short-Term Debt [Line Items]
Conversion price		$ 0.15
Number of shares issued		80,000
Director Agreement [Member] | Jeffrey Guzy [Member] | Share Price 0.08 [Member]
Short-Term Debt [Line Items]
Conversion price		$ 0.08
Number of shares issued		150,000
Director Agreement [Member] | Kimberly Kurtis [Member]
Short-Term Debt [Line Items]
Officers compensation								$ 1,000
Convertible notes payable	$ 10,000															10,000		10,000
Conversion of stock amount		$ 12,000
Conversion of stock, shares		80,000
Stock price per share		$ 0.15
Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Tranche #1 [Member]
Short-Term Debt [Line Items]
Interest debt														5.00%
Debt maturity date														Dec. 31, 2021
Accrued interest						$ 2,351
Interest expenses																0	$ 100	0	350
Debt issued amount														$ 20,000
Conversion price														$ 0.16
Conversion of stock amount						$ 20,000
Number of shares issued						139,692
Beneficial conversion feature														$ 20,000
Amortization of debt discount																0	0	0	0
Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Tranche #1 [Member] | Extended Maturity [Member]
Short-Term Debt [Line Items]
Debt maturity date						Apr. 30, 2022
Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Tranche #2 [Member]
Short-Term Debt [Line Items]
Interest debt													5.00%
Debt maturity date													Jan. 01, 2022
Accrued interest						$ 9,743
Interest expenses																	450		1,500
Debt issued amount													$ 86,000
Conversion price													$ 0.16
Conversion of stock amount						$ 86,000
Number of shares issued						598,392
Beneficial conversion feature													$ 32,250
Amortization of debt discount																0	1,412	0	1,412
Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Tranche #2 [Member] | Extended Maturity [Member]
Short-Term Debt [Line Items]
Debt maturity date						Apr. 30, 2022
Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Tranche #3 [Member]
Short-Term Debt [Line Items]
Interest debt												5.00%
Debt maturity date												Feb. 01, 2022
Accrued interest						$ 7,851
Interest expenses																	375		1,260
Debt issued amount												$ 72,000
Conversion price												$ 0.16
Conversion of stock amount						$ 72,000
Number of shares issued						499,068
Beneficial conversion feature												$ 36,000
Amortization of debt discount																		0	3,103
Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Tranche #3 [Member] | Extended Maturity [Member]
Short-Term Debt [Line Items]
Debt maturity date						Apr. 30, 2022
Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Tranche #4 [Member]
Short-Term Debt [Line Items]
Interest debt											5.00%
Debt maturity date											Nov. 25, 2022
Accrued interest						$ 55,401
Interest expenses																0	7,500	0	17,700
Debt issued amount											$ 822,000
Conversion price											$ 0.16
Conversion of stock amount						$ 822,000
Number of shares issued						5,483,753
Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Tranche #5 [Member]
Short-Term Debt [Line Items]
Interest debt										5.00%
Debt maturity date										Mar. 17, 2023
Accrued interest						$ 30,656
Interest expenses																0	1,700	0	8,800
Debt issued amount										$ 579,769
Conversion price										$ 0.088
Conversion of stock amount						$ 579,769.39
Number of shares issued						6,936,656
Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Tranche #6 [Mmeber]
Short-Term Debt [Line Items]
Interest debt							5.00%
Debt maturity date							Mar. 14, 2024
Accrued interest						$ 2,908
Interest expenses																	2,908		2,908
Debt issued amount							$ 884,429
Conversion price							$ 0.088
Conversion of stock amount						$ 884,492
Number of shares issued						10,084,093
Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Tranche #7 [Mmeber]
Short-Term Debt [Line Items]
Interest debt					5.00%
Debt maturity date					Aug. 30, 2024
Interest expenses																5,805	5,805	11,610	11,610
Debt issued amount					$ 470,862
Conversion price					$ 0.39
Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Tranche #8 [Mmeber]
Short-Term Debt [Line Items]
Interest debt				5.00%
Debt maturity date				Aug. 30, 2024
Interest expenses																1,726		3,453
Debt issued amount				$ 140,027
Conversion price				$ 0.39
Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Tranche #9 [Mmeber]
Short-Term Debt [Line Items]
Interest debt			5.00%
Debt maturity date			Feb. 28, 2025
Interest expenses																$ 3,801		$ 3,801
Debt issued amount			$ 308,320
Conversion price			$ 0.39
Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Tranche #10 [ Member]
Short-Term Debt [Line Items]
Interest debt	8.00%															8.00%		8.00%
Debt maturity date	May 31, 2025
Interest expenses																$ 0		$ 0
Debt issued amount	$ 412,533															$ 412,533		$ 412,533
Conversion price	$ 0.10															$ 0.10		$ 0.10
Unsecured Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Subsequent Event [Member]
Short-Term Debt [Line Items]
Interest debt																				8.00%
Debt issued amount																				$ 1,000,000
Conversion price																				$ 0.10
A. Scott Dockter [Member]
Short-Term Debt [Line Items]
Note payable balance	$ 13,716															$ 13,716		$ 13,716					28,716
Interest debt																								6.00%
Accrued interest	$ 41,779															41,779		41,779					$ 41,167
Interest expenses																233	837	612	1,706
Debt issued amount																								$ 197,096
Repayments notes payable																		15,000
Bayshore Capital Advisors, LLC [Member]
Short-Term Debt [Line Items]
Equity Method Investment, Ownership Percentage															10.00%
Note payable balance															$ 25,000
Interest debt															6.00%
Debt maturity date															Aug. 26, 2016
Cancellation amount																						$ 25,000
Accrued interest																						$ 10,146
Interest expenses																$ 0	$ 380	$ 255	$ 750

XML

SCHEDULE OF LEASE COST AND OTHER SUPPLEMENTAL LEASE INFORMATION (Details) - USD ($)	6 Months Ended
	May 31, 2023	May 31, 2022	Nov. 30, 2022
Leases
Operating lease cost (cost resulting from lease payments)	$ 21,000	$ 9,000
Short term lease cost
Sublease income
Net lease cost	21,000	9,000
Operating lease - operating cash flows (fixed payments)	21,000	9,000
Operating lease - operating cash flows (liability reduction)	19,197	8,688
Non-current leases - right of use assets	59,699	7,109	$ 79,599
Current liabilities - operating lease liabilities	39,869	7,407	38,882
Non-current liabilities - operating lease liabilities	$ 20,696		$ 40,880

XML

SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS (Details)	May 31, 2023 USD ($)
Leases
Remainder of 2023	$ 31,500
2024	31,500
Total future minimum lease payments	63,000
Amount representing interest	(2,435)
Present value of net future minimum lease payments	$ 60,565

XML

SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($)	May 31, 2023	Nov. 30, 2022
Payables and Accruals [Abstract]
Accounts payable	$ 316,496	$ 30,078
Accrued interest – related party	66,595	57,266
Accrued compensation	29,466	28,134
Accounts payable and accrued expenses	$ 412,557	$ 115,478

XML

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	Apr. 28, 2023	Jul. 08, 2020	Mar. 29, 2019
Superior Soils Supplements LLC [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Complaint seeks damages	$ 125,000		$ 400,000
Damages accrual			$ 400,000
Chief Financial Officer, Al Calvanico [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Complaint seeks damages		$ 600,000

XML

STOCKHOLDERS’ EQUITY (Details Narrative) - $ / shares	Jun. 09, 2023	Jun. 17, 2022
Scrivener Agreement [Member] | Dr Scrivener [Member] | Subsequent Event [Member]
Stock issued during period, shares, issued for services	100,000
Share price	$ 0.08
Newbridge Securities Corporation [Member]
Number of shares issued		300,000
Price per share		$ 0.35

XML

SCHEDULE OF BLACK-SCHOLES OPTION MODEL ASSUMPTIONS (Details) - USD ($)	6 Months Ended
	May 31, 2023	May 31, 2022	Nov. 30, 2022	Nov. 30, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options	128,688,187	117,795,000	128,688,187	117,795,000
Exercise Price
Option 1 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant Date	Apr. 08, 2021
Number of Options	250,000
Share price	$ 0.15
Exercise Price	$ 0.10
Expected Volatility	281.00%
Risk-free Interest Rate	0.85%
Dividend Rate	0.00%
Expected Term	2 years 6 months
Fair Value	$ 36,708
Option 2 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant Date	Aug. 13, 2021
Number of Options	200,000
Share price	$ 0.46
Exercise Price	$ 0.36
Expected Volatility	266.00%
Risk-free Interest Rate	0.79%
Dividend Rate	0.00%
Expected Term	3 years 6 months
Fair Value	$ 90,944
Option 3 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant Date	Oct. 06, 2021
Number of Options	116,000,000
Share price	$ 0.38
Exercise Price	$ 0.38
Expected Volatility	278.00%
Risk-free Interest Rate	1.26%
Dividend Rate	0.00%
Expected Term	3 years 10 months 17 days
Fair Value	$ 43,808,780
Option 4 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant Date	Jun. 03, 2022
Number of Options	8,669,400
Share price	$ 0.22
Exercise Price	$ 2.50
Expected Volatility	274.50%
Risk-free Interest Rate	2.95%
Dividend Rate	0.00%
Expected Term	3 years 6 months
Fair Value	$ 1,856,151
Option 5 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant Date	Aug. 26, 2022
Number of Options	1,734,615
Share price	$ 0.24
Exercise Price	$ 0.24
Expected Volatility	269.24%
Risk-free Interest Rate	3.20%
Dividend Rate	0.00%
Expected Term	3 years 6 months
Fair Value	$ 411,668
Option 6 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant Date	Aug. 26, 2022
Number of Options	242,424
Share price	$ 0.24
Exercise Price	$ 0.24
Expected Volatility	276.76%
Risk-free Interest Rate	3.20%
Dividend Rate	0.00%
Expected Term	3 years
Fair Value	$ 57,264
Option 7 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant Date	Aug. 26, 2022
Number of Options	246,748
Share price	$ 0.24
Exercise Price	$ 0.24
Expected Volatility	207.37%
Risk-free Interest Rate	3.20%
Dividend Rate	0.00%
Expected Term	2 years 6 months
Fair Value	$ 53,479

XML

SCHEDULE OF STOCK OPTION ACTIVITY (Details) - $ / shares	6 Months Ended
	May 31, 2023	May 31, 2022
Share-Based Payment Arrangement [Abstract]
Outstanding Options	128,688,187	117,795,000
Weighted- Average Exercise Price	$ 0.53	$ 0.39
Number of Options, Granted
Weighted Average Exercise Price, Granted
Number of Options, Exercised
Weighted Average Exercise Price, Exercised
Number of Options, Expired or Cancelled
Weighted Average Exercise Price, Expired or Cancelled
Outstanding Options	128,688,187	117,795,000
Weighted- Average Exercise Price	$ 0.53	$ 0.39

XML

SCHEDULE OF STOCK OPTION SHARES OUTSTANDING AND EXERCISABLE (Details)	6 Months Ended
	May 31, 2023 $ / shares shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Outstanding Options	128,688,187
Weighted- Average Remaining Life in Years	5 years 5 months 8 days
Weighted- Average Exercise Price | $ / shares	$ 0.53
Number Exercisable	128,688,187
Exercise Price One [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices | $ / shares	$ 0.10
Outstanding Options	400,000
Weighted- Average Remaining Life in Years	1 year 4 months 20 days
Weighted- Average Exercise Price | $ / shares	$ 0.10
Number Exercisable	400,000
Exercise Price Two [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices | $ / shares	$ 0.10
Outstanding Options	645,000
Weighted- Average Remaining Life in Years	2 years 6 months 14 days
Weighted- Average Exercise Price | $ / shares	$ 0.10
Number Exercisable	645,000
Exercise Price Three [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices | $ / shares	$ 0.12
Outstanding Options	50,000
Weighted- Average Remaining Life in Years	5 years 6 months 25 days
Weighted- Average Exercise Price | $ / shares	$ 0.12
Number Exercisable	50,000
Exercise Price Four [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices | $ / shares	$ 0.24
Outstanding Options	2,223,787
Weighted- Average Remaining Life in Years	4 years 1 month 28 days
Weighted- Average Exercise Price | $ / shares	$ 0.24
Number Exercisable	2,223,787
Exercise Price Five [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices | $ / shares	$ 0.36
Outstanding Options	200,000
Weighted- Average Remaining Life in Years	3 years 5 months 12 days
Weighted- Average Exercise Price | $ / shares	$ 0.36
Number Exercisable	200,000
Exercise Price Six [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices | $ / shares	$ 0.38
Outstanding Options	116,000,000
Weighted- Average Remaining Life in Years	5 years 7 months 2 days
Weighted- Average Exercise Price | $ / shares	$ 0.38
Number Exercisable	116,000,000
Exercise Price Seven [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices | $ / shares	$ 2.50
Outstanding Options	8,669,400
Weighted- Average Remaining Life in Years	4 years 3 months 3 days
Weighted- Average Exercise Price | $ / shares	$ 2.50
Number Exercisable	8,669,400
Exercise Price Eight [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices | $ / shares	$ 3.00
Outstanding Options	500,000
Weighted- Average Remaining Life in Years	3 years 3 days
Weighted- Average Exercise Price | $ / shares	$ 3.00
Number Exercisable	500,000

XML

STOCK-BASED COMPENSATION (Details Narrative) - USD ($)				3 Months Ended		6 Months Ended
	Aug. 26, 2022	Jun. 03, 2022	Nov. 10, 2017	May 31, 2023	May 31, 2022	May 31, 2023	May 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares of common stock granted exercisable options
Exercise price
Stock option exercisable term						10 years
Vesting period, description						vest over various terms from the grant date to five years.
Compensation expense						$ 7,326,402	$ 18,254,083
Fair value of common stock
Equity Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation expense				$ 1,841,389	$ 7,304,345	$ 7,326,402	$ 18,254,083
Future compensation cost related to non-vested stock options				$ 0		0
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average grant date fair value of options, non-vested						0	$ 10,917,826
Member of Board, Consultants and Employees [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares of common stock granted exercisable options	2,223,787
Exercise price	$ 0.24
Fair value	$ 522,411
Option Holders [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation, aggregate intrinsic value						$ 31,155
Fair value of common stock						$ 0.13
Settlement Agreement [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares of common stock granted exercisable options		8,669,400
Exercise price		$ 2.50
Fair value		$ 1,856,151
2017 Equity Incentve Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares of common stock granted exercisable options			10,000,000			128,688,187
2017 Equity Incentve Plan [Member] | Employment Contracts [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares of common stock granted exercisable options			500,000

XML

RELATED PARTY TRANSACTIONS (Details Narrative)									3 Months Ended		6 Months Ended
	Jun. 09, 2023 $ / shares shares	Oct. 06, 2021 $ / shares shares	Aug. 13, 2021 USD ($)	May 27, 2021 USD ($) $ / shares	Apr. 08, 2021 USD ($)	Oct. 01, 2020 USD ($) ft²	Apr. 22, 2020 USD ($)	Feb. 26, 2016 USD ($)	May 31, 2023 USD ($) ft²	May 31, 2022 USD ($)	May 31, 2023 USD ($) ft² shares	May 31, 2022 USD ($) shares	Jul. 10, 2023 USD ($) $ / shares	Apr. 06, 2023 shares	Mar. 07, 2023 USD ($)	Feb. 28, 2023	Feb. 04, 2023 USD ($)	Nov. 30, 2022 USD ($)	Oct. 06, 2022 shares	Apr. 06, 2022 shares	Aug. 31, 2017 USD ($)
Cash advances											$ 705,000	$ 410,000
Debt issued amount															$ 412,533
Share-based payment award options grants in period | shares
Share-based payment arrangement noncash expense											$ 7,326,402	$ 18,254,083
Officers compensation											12,000
Operating lease monthly rent expense											$ 3,500
Office space | ft²									700		700
A. Scott Dockter [Member]
Notes payable									$ 13,716		$ 13,716							$ 28,716
Debt instrument interest rate stated percentage																					6.00%
Interest expense									41,779		41,779							41,167
Interest expense									233	$ 837	612	1,706
Debt issued amount																					$ 197,096
Repayments short term debt											15,000
Director Agreement [Member] | Jeffrey Guzy [Member]
Debt instrument interest rate stated percentage					0.00%
Officers compensation					$ 1,000
Director Agreement [Member] | Kimberly Kurtis [Member]
Officers compensation			$ 1,000
Subsequent Event [Member] | Scrivener Agreement [Member] | Dr Scrivener [Member]
Stock issued during period, shares, issued for services | shares	100,000
Share price | $ / shares	$ 0.08
Unsecured Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Subsequent Event [Member]
Debt instrument interest rate stated percentage													8.00%
Debt issued amount													$ 1,000,000
Conversion price | $ / shares													$ 0.10
US Mine Corporation [Member]
Interest expense									11,333	13,033	18,864	32,518
Payment for purchases made											34,364	0
Cash advances											15,853	4,438
Convertible note payable balance									406,604		406,604							0
Convertible debt									1,331,742		1,331,742							$ 610,889
Operating lease monthly rent expense						$ 1,500
Lease extension term						2 years
Office space | ft²						700
Operating lease monthly rent expense						$ 3,500
US Mine Corporation [Member] | Material Supply Agreement [Member]
Payments for inventory							$ 292,806		12,450	72,236	34,365	72,236
US Mine Corporation [Member] | Material Supply Agreement [Member] | Kaolin Clay for Supplementary Cementitious Materials [Member]
Payments to materials and products for agriculture, per ton							25
US Mine Corporation [Member] | Material Supply Agreement [Member] | Bagged Products for Clay [Member]
Payments to materials and products for agriculture, per ton							145
Royalty fee, per ton							$ 5
US Mine, LLC [Member] | Materials Extraction Agreement [Member]
Debt instrument interest rate stated percentage				2.50%
Convertible note payable balance				$ 50,000,000
Conversion price | $ / shares				$ 0.43
Royalty fee, per ton				$ 5.00
Extraction agreement description				On May 27, 2021, the Company entered into the Materials Extraction Agreement with US Mine, LLC, pursuant to which the Company acquired the right to extract up to 100,000,000 of certain raw clay materials. The Materials Extraction Agreement is effective until 100,000,000 tons of material are extracted.
Debt conversion description				The noteholder may convert (i) up to 50% of the outstanding balance on or after such date as the Company’s common stock is listed for trading on any national securities exchange, (ii) up to an additional 25% of the outstanding balance on or after the six-month anniversary of such initial trading date, and (iii) the remaining 25% on or after the twelve-month anniversary of such initial trading date. In addition, the Company will pay US Mine, LLC a royalty fee of $5.00 per ton of materials extracted and any royalty not paid in a timely manner with be subject to 15% interest per annum and compounded monthly
Share-based payment award options grants in period | shares		116,000,000
Common stock exercise price | $ / shares		$ 0.38
Options vested and expected to vest outstanding number | shares														29,000,000					29,000,000	58,000,000
Share-based payment arrangement noncash expense									1,841,389		7,326,402
Bayshore Capital Advisors, LLC [Member]
Ownership percent								10.00%
Notes payable								$ 25,000
Debt instrument interest rate stated percentage								6.00%
Debt instrument maturity date								Aug. 26, 2016
Debt cancellation amount																	$ 25,000
Interest expense																	$ 10,146
Interest expense									$ 0	$ 380	$ 255	$ 750
USMC [Member]
Ownership percent																33.00%

XML

SCHEDULE OF CONCENTRATION OF CREDIT RISK (Details)	6 Months Ended
	May 31, 2023	May 31, 2022
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Customer A [Member]
Concentration Risk [Line Items]
Concentration risk percentage	44.00%	84.00%
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Customer B [Member]
Concentration Risk [Line Items]
Concentration risk percentage	40.00%	8.00%
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Customer C [Member]
Concentration Risk [Line Items]
Concentration risk percentage	15.00%	8.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer A [Member]
Concentration Risk [Line Items]
Concentration risk percentage	73.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer B [Member]
Concentration Risk [Line Items]
Concentration risk percentage	27.00%
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor A [Member]
Concentration Risk [Line Items]
Concentration risk percentage		31.00%
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor B [Member]
Concentration Risk [Line Items]
Concentration risk percentage		16.00%
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor C [Member]
Concentration Risk [Line Items]
Concentration risk percentage		13.00%

XML

CONCENTRATION OF CREDIT RISK (Details Narrative) - USD ($)	3 Months Ended	6 Months Ended
	May 31, 2023	May 31, 2023	May 31, 2022	Nov. 30, 2022
Concentration Risk [Line Items]
FDIC insured amount	$ 250,000	$ 250,000
Account receivables	$ 66,376	$ 66,376
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Three Customers [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		99.00%	100.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		100.00%
Accounts Payable [Member] | Supplier Concentration Risk [Member] | One Suppliers [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	100.00%
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Three Suppliers [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			60.00%

XML

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Jul. 10, 2023	Mar. 07, 2023
Subsequent Event [Line Items]
Debt issued amount		$ 412,533
Unsecured Convertible Promissory Notes [Member] | US Mine Corporation [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Debt issued amount	$ 1,000,000
Simple interest at an annual rate	8.00%
Debt conversion price	$ 0.10